Utilization of Carbon Nanofibers Grown on Glass Microballoons (NMBs) in Point-of-Care Diagnostic Devices by Gikunoo, Emmanuel
Louisiana State University
LSU Digital Commons
LSU Doctoral Dissertations Graduate School
2014
Utilization of Carbon Nanofibers Grown on Glass
Microballoons (NMBs) in Point-of-Care
Diagnostic Devices
Emmanuel Gikunoo
Louisiana State University and Agricultural and Mechanical College
Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Mechanical Engineering Commons
This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in
LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please contactgradetd@lsu.edu.
Recommended Citation
Gikunoo, Emmanuel, "Utilization of Carbon Nanofibers Grown on Glass Microballoons (NMBs) in Point-of-Care Diagnostic
Devices" (2014). LSU Doctoral Dissertations. 2010.
https://digitalcommons.lsu.edu/gradschool_dissertations/2010
 
UTILIZATION OF CARBON NANOFIBERS GROWN ON GLASS 














Submitted to the Graduate Faculty of the 
Louisiana State University and 
Agricultural and Mechanical College 
in partial fulfillment of the  
requirements for the degree of 





















B.Sc., Kwame Nkrumah University of Science and Technology, 1999 
M.Sc., University of Saskatchewan, 2005 













To my lovely kids 









It is with humility and appreciation that I wish to acknowledge the great minds that have brought 
me this far in my academic journey. My sincere appreciation goes to my advisor, Dr. Eyassu 
Woldesenbet, for his thoughtful insights, mentorship and advice throughout this research. Special 
thanks also go to my dissertation committee members, Dr. Ying Wang, Dr. Ram Devireddy, and 
Dr. Evgueni E. Nesterov for their useful suggestions. Technical assistance provided by Dr. 
Matthew Brown at the LSU Socolofsky Microscopy Center is gratefully acknowledged. 
 
I am equally grateful to my mentors and colleagues at the Next Generation Composites Crest 
Center, Southern University and A & M College, especially Dr. Patrick Mensah, Dr. Yoonyoung 
Jin, Dr. Adeyabeba Abera, Dr. Ali Ghamsari, Dr. Ephraim Zegeye, Dr. Fareed Dawan, and Jude 
Mgbanwunne whose contributions and encouragements have taken me this far. Without them this 
journey would not have come to a successful end. To my best friends and motivators, Dr. Anthony 
Andrew and Dr. Patrick Feglo, thanks for bringing me this far. You have and continue to be my 
source of encouragement. 
 
Words cannot express my sincerest appreciation to my wife, kids, mum, dad, and siblings. Your 
immense support, love and sacrifices are endless. To my auntie, Victoria Tetteh and her kids, your 
help and sacrifices have brought me this far. I would also like to thank the Ghanaian community 
at LSU: Julius Codjoe and family, Godfrey Mills, William Armah, Wisdom Wardy, Owen Boaitey, 
Emmanuel Kyereh, and Nutifafa Adotey, the support and candid pieces of advice we share are 
greatly appreciated.  
 
Finally, to everyone that has been part of my life along this journey, may God richly bless you.  
iv 
 
TABLE OF CONTENTS 
 
ACKNOWLEDGEMENTS ........................................................................................................... iii 
 
LIST OF TABLES ........................................................................................................................ vii 
 
LIST OF FIGURES ..................................................................................................................... viii 
 
ABSTRACT ................................................................................................................................... xi 
 
CHAPTER 1 
INTRODUCTION .......................................................................................................................... 1 
1.1 Motivation ........................................................................................................................ 1 
1.1.1 Point-of-Care (POC) Diagnostic Devices ................................................................. 1 
1.1.2 Carbon Nanofibers .................................................................................................... 3 
1.1.3 Carbon Nanofibers Grown on Glass Microballoons (NMBs) .................................. 4 
1.2 Research Objectives ......................................................................................................... 6 
1.3 Outline of Dissertation ..................................................................................................... 7 
 
CHAPTER 2 
FABRICATION AND SURFACE FUNCTIONALIZATION OF CARBON          
NANOFIBERS GROWN ON GLASS MICROBALLOONS ....................................................... 8 
2.1 Introduction ...................................................................................................................... 8 
2.2 Structure of CNF ............................................................................................................ 11 
2.3 Surface Functionalization of CNFs ................................................................................ 14 
2.4 Experimental Procedures................................................................................................ 18 
2.4.1 Catalyst Coating of Glass Microballoons ............................................................... 18 
2.4.2 CNF Growth............................................................................................................ 19 
2.4.3 Surface Functionalization of CNF .......................................................................... 20 
2.4.4 Characterization ...................................................................................................... 21 
2.5 Results and Discussions ................................................................................................. 22 
2.5.1 Catalyst Layer Formation ....................................................................................... 22 
2.5.2 CNF Growth............................................................................................................ 25 
2.5.3 Surface Functionalization Results........................................................................... 27 
2.6 Summary ........................................................................................................................ 32 
 
CHAPTER 3 
IMMUNOASSAY ON GLASS SLIDE USING CARBON NANOFIBERS GROWN ON 
GLASS MICROBALLOONS (NMBs) ........................................................................................ 34 
3.1 Introduction .................................................................................................................... 34 
3.2 Antibodies as Recognition Elements.............................................................................. 37 
3.3 Binding of Antibodies to Carbon Nanofibers ................................................................ 40 
3.4 Blocking as a Means of Preventing Non-Specific Binding ............................................ 42 
3.5 Detection Principle ......................................................................................................... 44 
3.5.1 Biomolecule – NMBs Conjugation ......................................................................... 44 
3.5.2 NMBs Immobilization on Glass Slide .................................................................... 45 
v 
 
3.6 Experimental Procedures................................................................................................ 46 
3.6.1 Blocking .................................................................................................................. 47 
3.6.2 Functionalization of NMBs with EDC/Sulfo-NHS ................................................ 47 
3.6.3 Biomolecule – NMBs Conjugation ......................................................................... 47 
3.6.4 Preparation of Immunosensor ................................................................................. 49 
3.6.5 Imaging ................................................................................................................... 51 
3.6.6 Electrical Measurements ......................................................................................... 51 
3.7 Results and Discussion ................................................................................................... 52 
3.7.1 EDC/Sulfo-NHS Functionalized NMBs ................................................................. 52 
3.7.2 Non-Specific Binding ............................................................................................. 53 
3.7.3 Conjugation of Biomolecules to NMBs .................................................................. 56 
3.7.4 Immunosensor ......................................................................................................... 60 
3.8 Summary ........................................................................................................................ 65 
 
CHAPTER 4 
ULTRA-LOW IMMUNOASSAY DETECTION OF MALARIA AND PREGNANCY             
IN HUMANS ................................................................................................................................ 67 
4.1 Introduction .................................................................................................................... 67 
4.2 Malaria ........................................................................................................................... 70 
4.3 Diagnosis of Malaria ...................................................................................................... 72 
4.3.1 Microscopy ............................................................................................................. 73 
4.3.2 Molecular ................................................................................................................ 74 
4.3.3 Serology .................................................................................................................. 75 
4.3.4 Antigen Detection ................................................................................................... 75 
4.4 Pregnancy ....................................................................................................................... 77 
4.5 Diagnosis of Pregnancy .................................................................................................. 78 
4.6 Experimental Procedures................................................................................................ 79 
4.6.1 Reagents and Materials ........................................................................................... 79 
4.6.2 NMB-Plasmodium Species Conjugation ................................................................ 79 
4.6.3 Preparation of Glass Substrate ................................................................................ 80 
4.6.4 Characterization ...................................................................................................... 81 
4.7 Results and Discussion ................................................................................................... 81 
4.7.1 Principle of Disease Detection ................................................................................ 81 
4.7.2 Detection Limit of PfHRP-2 Assay ........................................................................ 82 
4.7.3 Selectivity of the PfHRP-2 Detection Assay .......................................................... 87 
4.7.4 Selectivity of the hCG Detection Assay ................................................................. 90 
4.8 Summary ........................................................................................................................ 92 
 
CHAPTER 5 
CONCLUSIONS AND FUTURE WORK ................................................................................... 94 
5.1 Conclusions .................................................................................................................... 94 
5.1.1 Surface Functionalization of NMBs ....................................................................... 94 
5.1.2 Conjugation of Biological Species to NMBs .......................................................... 95 
5.1.3 Pathogen Detection on Immunochromatographic Device ...................................... 96 
5.2 Future Work ................................................................................................................... 97 
5.2.1 Pathogen Detection in Microfluidic Device ........................................................... 97 
vi 
 
5.2.2 Design and Optimization of Microfluidic Device .................................................. 98 
5.2.3 Clinical Trials using Microfluidic Device .............................................................. 99 
 
REFERENCES ............................................................................................................................. 99 
 
APPENDIX:  PERMISSION TO USE COPYRIGHTED MATERIAL .................................... 117 
 





LIST OF TABLES 
 
Table 4.1 Summary of the percent area of the capture zone covered with NMBs for            
varying PfHRP-2 concentrations………………………………………………… 84 
Table 4.2 Summary of the measured resistance values of the capture zone for varying 
PfHRP-2 concentrations…………………………………………………………. 87 
Table 4.3 Summary of the percent area of the capture zone covered with NMBs for     
varying PvMSP-1 concentrations………………………………………………... 90 
Table 4.4 Summary of the measured resistivity values of the capture zone for varying 
PvMSP-1 concentrations………………………………………………………… 90 
Table 4.5 Summary of the percent area of the capture zone covered with NMBs for     
varying hCG concentrations……………………………………………………... 91 
Table 4.6 Summary of the measured resistance values of the capture zone for varying      








LIST OF FIGURES 
 
Figure 1.1 CNTs grown on (a) hollow nickel microsphere [37], (b) ceramic beads [38]        
and (c) alumina microparticle [39]. .......................................................................... 5 
Figure 2.1 Schematics of the different structures of CNFs [40]. ............................................. 11 
Figure 2.2 Schematic of the CVD system. ............................................................................... 20 
Figure 2.3 Flow mechanism of electroless nickel deposition on glass microballoon. ............. 23 
Figure 2.4 Images of as-received microballoons, microballoons after electroless nickel 
deposition, and carbon nanofiber grown on nickel coated microballoons. ............ 23 
Figure 2.5 (a) SEM micrograph of nickel coated MBs and (b) typical optical micrograph      
of a layer of nickel coated MBs formed on silicon wafer [102]. ............................ 24 
Figure 2.6 FTIR spectra of (a) as received MB and (b) nickel coated MB. ............................. 24 
Figure 2.7 (a), (b) SEM micrographs of as-fabricated NMBs at different magnifications. ..... 26 
Figure 2.8 Raman spectra of as-fabricated CNFs [102]. .......................................................... 26 
Figure 2.9 The modification process of CNFs by HNO3 treatment. Carbonaceous      
fragments are represented by red wavy lines. Similar processes are found 
elsewhere [88]. ....................................................................................................... 28 
Figure 2.10 SEM micrographs of (a) air oxidized, (b) HNO3 oxidized, (c) HNO3/H2SO4,       
and (d) fractured and peeled off CNFs from acidic oxidization of MBs. .............. 29 
Figure 2.11 Dispersion of NMBs in PBS after modification with HNO3, HNO3/H2SO4,          
and air (from left to right). All solutions have 1 mg/ml concentration of          
NMBs and at times (a) just dispersed, (b) 2 minutes, and (c) 10 minutes. ............ 31 
Figure 2.12 FTIR Spectra of as-fabricated and the different types of surface oxidized      
samples used in the research. ................................................................................. 32 
Figure 3.1 Schematic structure of IgG [134]. ........................................................................... 39 
Figure 3.2 Reaction of the carboxylate functional group with a primary amine           
containing molecule, in the presence of EDC and sulfo-NHS [139]. .................... 41 
Figure 3.3 Schematic of the processing stages of a sandwich immunoassay protocol. ........... 44 
Figure 3.4 Schematic of the capture procedure of NMBs on glass slide. (a) NMBs,               
(b) secondary anti-IgG conjugated NMBs, (c) primary IgG immobilized on          
glass slide, (d) anti-IgG locked by immobilized primary IgG,                                
(e) immobilized NMBs on slide, and (f) signal detection setup. ............................ 45 
ix 
 
Figure 3.5 Schematic of increasing anti-IgG concentrations on NMBs network at the      
capture zone. ........................................................................................................... 46 
Figure 3.6 FTIR spectra of EDC/Sulfo NHS treated NMBs. ................................................... 53 
Figure 3.7 Dispersion of NMBs in PEG solution at times (a) just dispersed, (b) 10       
minutes, and (c) 20 minutes. .................................................................................. 54 
Figure 3.8 Fluorescence micrographs of anti-IgG-FITC bound to NMBs (a) without          
PEG and (b) with PEG. (c) Fluorescence micrograph of PEG treated NMBs 
initially conjugated with excess anti-IgG followed by treatment with anti-         
IgG-FITC. ............................................................................................................... 55 
Figure 3.9 FTIR spectra of PEG modified EDC/Sulfo NHS treated NMBs. ........................... 56 
Figure 3.10 Fluorescence micrographs of NMBs conjugated with IgG and further            
treated with (a) 0.01 ng/ml, (b) 1 ng/ml, and (c) 10 ng/ml of anti-IgG-FITC. ....... 58 
Figure 3.11 Fluorescence micrographs of NMBs conjugated with anti-IgG and further     
treated with (a) 0.01 ng/ml, (b) 1 ng/ml, and (c) 10 ng/ml of IgG-FITC. .............. 58 
Figure 3.12 Fluorescence micrographs of NMBs conjugated with IgG. The NMBs were      
then treated with varying anti-IgG concentrations followed by anti-IgG-          
FITC (a) 0.01 ng/ml, (b) 1 ng/ml, and (c) 50 ng/ml of anti-IgG. ........................... 59 
Figure 3.13. Fluorescence micrograph showing sandwich conjugation of IgG/anti-IgG/        
IgG-FITC on NMBs. .............................................................................................. 60 
Figure 3.14 NMBs immobilized on glass substrate using the sandwich format for IgG           
and anti-IgG biomolecules. .................................................................................... 62 
Figure 3.15 Optical micrographs showing NMBs captured on glass slides in a sandwich    
assay format with (a) 1, (b) 5, (c) 10, and (d) 50 ng/ml of anti-IgG 
concentrations. ........................................................................................................ 62 
Figure 3.16 Variation of percent area of the capture zone covered with NMBs against         
anti-IgG concentrations. ......................................................................................... 63 
Figure 3.17 Variation of the resistance of the capture zone with anti-IgG concentration          
for immobilized NMBs and CNTs. ........................................................................ 64 
Figure 4.1 Global distribution of malaria endemicity [170]. ................................................... 68 





Figure 4.3 (a) Schematic illustration of the sandwich immunochromatographic set-up        
used to detect PfHRP-2 and (b) Illustration of the two different types of          
signal generation from the immunosensor. The yellow cable is used for      
electrical measurements. ........................................................................................ 83 
Figure 4.4 Optical micrographs showing NMBs captured on glass slides in a sandwich     
assay format with (a) 0.025, (b) 0.1, (c) 1, and (d) 10 ng/ml concentrations           
of PfHRP-2. ............................................................................................................ 84 
Figure 4.5 (a) Variation of percent area of the capture zone covered with NMBs against 
PfHRP-2 concentrations and (b) Variation of the resistivity of the capture         
zone with immobilized PfHRP-2 concentration. The error bars in both            
graphs each shows the variation of five concentration points. ............................... 85 
Figure 4.6 Glass slides showing (a) visual signal obtained at the first capture zone from       
the detection of PfHRP-2 in PBS solution, (b) signal observed at the second 
capture zone from the detection of PvMSP-1 in solution, and (c) signals      
obtained at the PfHRP-2 and PvMSP-1 capture zones from a mixed              
PfHRP-2 and PvMSP-1 solution. ........................................................................... 88 
Figure 4.7 (a) Variation of percent area of the capture zone covered with NMBs against 
PvMSP-1 concentrations and (b) Variation of the resistivity of the capture        
zone with immobilized PvMSP-1 concentration. ................................................... 89 
Figure 4.8 (a) Variation of percent area of the capture zone covered with NMBs against    
hCG concentrations and (b) Variation of the resistivity of the capture zone        







The use of point-of-care (POC) diagnostic systems holds great promise for the early detection of 
various diseases. However, detection limits for commercially available POC systems have not 
been able to meet the lower cutoffs offered by the specialized laboratory testing methods. Research 
into the use of carbon nanofibers (CNFs) grown on glass microballoons in POC devices was 
studied.  
 
The growth of several millions of the CNFs on each microballoon (NMBs) presented a large 
surface area with high probability of capturing minute concentrations of biospecies. 
Functionalization of the NMBs with the carboxyl group needed for biospecies conjugation was 
achieved by air oxidation. This oxidation process makes our process environmental friendly to 
other downstream processes. Primary IgG was immobilized on glass slides. An 
immunochromatographic device was developed using a sandwich assay protocol to detect varying 
concentrations of immobilized anti-IgG on the slides. Covalent conjugated NMBs with secondary 
IgG were used in generating both visual and electrical signals. False signals were prevented by 
coating both the antibody immobilized slides and NMBs with surfactants. A lower visual detection 
limit of 0.010 ng/ml and faster detection (~ 1 min) were achieved for the IgG/anti-IgG detection. 
 
This promising result led to the modification of the immunochromatographic device for the 
detection of malaria infection and pregnancy. Plasmodium falciparum histidine rich protein-2 
(PfHRP-2) and Plasmodium vivax merozoites surface protein-1 (PvMSP-1) antigen were used for 
malaria testing. Human chorionic gonadotropin (hCG) was also used for pregnancy testing. The 
approach made it possible to detect PfHRP-2 and PvMSP-1 in PBS over their linear range of 0.01 
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– 10 ng/ml. The ultrasensitive approach resulted in detecting as low as 0.025 ng/ml of PfHRP-2 
and 0.025 ng/ml of PvMSP-1in PBS using visual signal within only one minute of testing. The 
approach is highly selective and specific in identifying PfHRP-2 from a mixed solution of PfHRP-
2 and PvMSP-1. A visual detection limit of 0.050 ng/ml of hCG in PBS was also obtained for the 
pregnancy antigen. Thus, the highly reactive, rapid, selective and signal amplification capabilities 









The advancement in technology is continuously changing the way the world operates. 
Improvements in disease detection devices are no exceptions. Research of incorporating carbon 
nanosized particles in disease detection devices has been growing. Carbon nanofibers (CNFs) with 
their high aspect ratios and large surface areas have been reported to provide numerous binding 
sites for biological entities [1-3]. Several millions of these CNFs can be grown on a glass 
microballoon (NMBs) thereby providing extensive areas for binding with bio species. The NMBs 
conjugated with secondary antibody will therefore have a significantly higher probability of 
capturing antigens in solution. Exploiting this advantage can lead to the discovery of a different 
generation of rapid detection kits (RDTs). These kits will have the advantages of being sensitive 
to minute protein concentrations and the ability to sense biomolecules in real time.  
 
1.1.1 Point-of-Care (POC) Diagnostic Devices 
Biosensors are devices that use specific biochemical reactions mediated by isolated enzymes, 
immunosystems, tissues, organelles or whole cells to detect chemical compounds usually by 
electrical, thermal or optical signals [4]. These sensors detect, transmit and record information 
regarding physiological, chemical and biological compounds of a living environment with the help 
of a specific biological recognition element. The ability of a biosensor to function effectively 
depends on its sample handling, bio-recognition, transduction and signal interpretation 
efficiencies. Biosensors are designed to analyze minute volumes of analyte in solution, usually a 
drop of blood. Bio-recognition is achieved when the biomolecule recognizes the target analyte. 
The transducer converts the recognition event into measurable signals generated in the form of 
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electrical, optical, thermal, chemical, mechanical or magnetic outputs [5-10]. Biomolecules 
currently being used are antibodies [6], enzymes [5, 7], deoxyribonucleic acid (DNA) [11], and 
whole cells [12]. 
 
There is an increasing demand for inexpensive and reliable sensors for use in doctor’s offices, 
emergency and operating rooms. Ultimately, patients themselves should reliably be able to use 
biosensors in the monitoring of a clinical condition, such as diabetes and malaria. Currently, the 
major biosensor market is mainly found in highly developed countries. However, most of the top 
deadly diseases, such as malaria, diarrhea and tuberculosis, are found in developing countries 
where access to disease detection in some areas is greatly limited. These diseases require highly 
specialized equipment and personnel in their diagnostics. Producing biosensors for use in detecting 
these deadly diseases, and making them widely available and affordable, will help in detection at 
early stages leading to less mortality of patients. 
 
POC test kits are gaining increasing popularity in the world [13]. Their need in low-resource 
settings are striking. These kits are used in lieu of diagnostic testing in hospital laboratories, 
because conventional services may be too distant, prohibitively costly, or in mostly cases 
unavailable. Gains have started to be obtained by healthcare professionals in rapidly obtaining 
common laboratory results either at or near patient’s bedside or in their offices. Benefits from their 
use will include the improvement in decision making and triage, reduction in operating times, 
reduction in emergency room visits, reduction in number of outpatient clinic visits, reduction in 




Rapid detection kits (RDT) are based on immunoassays methods that are able to directly identify 
the presence of microorganism in a sample. These rely on the specific binding of an antigen to its 
antibody. This method combines the specificity of antibodies which are usually immobilized on 
solid supports, like polystyrene tubes or microtiter plates, with the sensitivity of conjugated 
enzymes [14]. However, an incubation period of a few minutes is necessary prior to the 
interpretation of the biochemical reactions. Examples of some of these RDT are the Clearblue 
pregnancy kits [15] which has 3 minutes incubation time and BinaxNow Malaria kit [16] with 10 
minutes incubation period. Although these immunoassay kits are rapid, real time sensing devices 
are the ultimate goal for all biosensing devices, hence the need for incorporation of instant labels. 
Also, their mechanism is based on fluorescent emission which requires the use of specific dyes for 
labeling of samples [14]. False alarms sometimes result due to the use of these dyes leading to 
inconclusive or wrong diagnostics. The use of alternate labeling agents, such as Carbon 
Nanofibers, in RDT will lead to improvements in their outputs. 
 
1.1.2 Carbon Nanofibers 
The existence of carbon nanostructures dates back to the 19th century [17, 18]. However, it was in 
the early 1980s that unprecedented research began in the area of carbon nanostructures [19-23]. 
This led to a rapid increase in the numbers of discovered carbon nanostructures. The fullerenes, 
nanotubes, carbon toroidal structures, nanocones, and the helicoidal tubes [19-23] are examples of 
those discovered few years thereafter. The fibrous nanostructures, carbon nanotubes (CNTs) and 
CNFs, have ordered arrangements with high aspect ratio, ultra-light weight, biocompatibility, high 
reactivity, high mechanical strength, high thermal conductivity, metallic or semi-metallic 
behavior, and very high surface area which can be exploited in biosensing devices [24]. 
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Rolled graphene sheets, hexagonally arranged sp2 bonded carbon atoms, are the building block of 
the carbon nanofibers. In CNFs, these graphene sheets are stacked at an angle to the fiber axis 
whiles the CNTs have the sheets running parallel to the fiber axis [25]. CNFs therefore have 
relatively larger diameters, up to 500 nm, and up to a few millimeters in length. The overwhelming 
research in CNTs after its discovery by Iijima [20] attracted and continues to draw interest in 
several scientific fields such as chemistry, physics, biology, medicine, biochemistry and 
electronics. However, CNFs have some advantages over CNTs in microfluidic applications due to 
their larger inner diameter and the presence of graphene edge planes, which are ledges of carbon 
that protrude from the surface at regular intervals [26]. The fibrous carbon nanostructures are also 
known to be highly reactive at their end caps and the defect regions on their sidewalls [27]. These 
sites, when exploited for chemically immobilizing biological species in biosensing applications, 
will lead to the fabrication of highly sensitive devices. Price and his colleagues reported the 
bonding of bone cells with CNFs due to the protrusion of these ledges of carbon in the CNFs 
structure [26]. These numerous plane terminations of CNFs, unlike the passive graphene surfaces 
of CNTs, can be modified easily and applied in biosensing applications [3]. 
 
1.1.3 Carbon Nanofibers Grown on Glass Microballoons (NMBs) 
Research in the potential use of CNTs and CNFs based nano-devices for ultrasensitive sensing is 
widely being pursued with several demonstrations confirming the exciting possibilities ahead [28-
32]. Smaller and lightweight sensors with higher sensitivity and ability to sense in real time will 
revolutionize the way detections are made. However, utilization of carbon nanofibers in sensing 
devices pose challenges. Though they lead to improvements in the sensitivity of these devices, 
their reliability is questionable. This comes to light when attempting detection of multiple 
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molecules in a sample. A large range of signal fluctuations has been encountered due to statistical 
reasons [33]. The ability to organize these fibers into well-defined spatial orientations will improve 
their reliability leading to their potential use in various applications.  
 
Chemical modification combined with self-assembly of individual CNTs/CNFs [34, 35] and a 
multistep chemical vapor deposition (CVD) process [36] are some methods being used to construct 
carbon nanofiber superstructures. Employing a direct and relatively simple method of enabling the 
position of CNFs on the surface of other useful three dimensional structures could help grow CNFs 
forest for applications in biosensing devices. Hollow nickel microspheres [37], ceramic beads [38], 
and alumina microparticles [39] are examples of some of the three dimensional structures on which 





Figure 1.1 CNTs grown on (a) hollow nickel microsphere [37], (b) ceramic beads [38] and (c) 
alumina microparticle [39]. 
 
Catalyst coated hollow glass microballoons made from soda-lime borosilicate glass also has a 
potential of being used in growing vertically aligned CNFs using the CVD route. Growing these 
CNFs on glass microballoons (NMBs) has the potential of being utilized in point-of-care 





limits, improved sensitivity, easy handling of labeling materials, and ability to quantify the level 
of infection. Their use could lead to medical results being made available quicker to the patient 
and the care team allowing immediate clinical management decisions to be made. 
 
1.2 Research Objectives 
The ability to provide immediate diagnosis to patients has been an area of study in the sensing 
community for some time now. Various rapid detection kits have evolved over time. The 
pregnancy test kit which analyzes urine samples in a minimum of 3 minutes and the malaria rapid 
test kits which have a minimum detection time of 10 minutes are a few of POC kits commercially 
available. More sensitive and real time detection can be achieved if NMBs are incorporated into 
these devices. 
 
This study proposes the development of a POC testing kit for microorganisms in which NMBs are 
used as label. Successful growth of several CNFs on a glass microsphere will increase the 
probability of capture of antigens thereby improving the reliability of the CNFs for electrical and 
optical detection. This will be the first attempt in fabricating instant diagnostics POC devices with 
ultra-low detection limit, high sensitivity and selective detection of minute concentrations of 
multiple disease causing antigens simultaneously. Plasmodium falciparum, Plasmodium vivax, 
and human chorionic gonadotropin will be used as markers for the study. Visual observation and 
electrical measurement will be employed for signal detection. Quantification of varying marker 




1.3 Outline of Dissertation 
This dissertation contains six chapters. Chapter 1 presents the motivation and objectives of this 
research. It also introduces POC devices, CNFs, and CNFs grown on 3D structures. Chapter 2 
describes the relevant structures and surface functionalization protocols for CNFs. Experimental 
procedures and results for fabricating and functionalizing the surface of CNFs are also presented. 
Chapter 3 introduces antibodies, their binding to CNFs, and modes of preventing nonspecific 
binding in CNFs. Studies on the conjugation of immunoglobulin G (IgG) and anti-IgG to NMBs 
and their use as a platform in immobilizing the conjugated NMBs on glass slides are reported. 
Chapter 4 introduces malaria and the various methods of diagnosing the disease. Pregnancy, a 
clinical condition is also introduced and its diagnostic methods briefly outlined. An 
immunochromatographic sensor is proposed that incorporates NMBs to selectively and sensitively 
detect ultra-low concentrations of malaria and pregnancy antigens in solution. Results and 
discussions from the sensor are presented. Finally, Chapter 5 summarizes the results obtained from 






FABRICATION AND SURFACE FUNCTIONALIZATION OF CARBON NANOFIBERS 
GROWN ON GLASS MICROBALLOONS 
 
2.1 Introduction 
The study and applications of carbon nanostructures have grown since the reported discovery of 
CNTs by Iijima in 1991 [20]. Although CNTs and CNFs are synthesized using similar setups, their 
major difference results from the angle of inclination of the rolled graphene sheets. While CNTs 
are rolled up in a cylindrical form with their plane parallel to the fiber axis, CNFs have their 
graphene layers inclined with respect to their fibril axis [40]. These differences in inclination are 
as a result of differences in fabrication temperatures. Hence CNFs are relatively larger in diameter, 
up to 500 nm, compared to the CNTs. Benefits of using CNFs over CNTs include relatively easier 
synthesis methods and ease in their dispersion and functionalization. Other properties of these 
materials have been reported to be similar by several authors [25, 40-43] although better 
controllability of the location and size of CNFs compared with CNTs have also been reported [44]. 
 
Arc discharge, laser ablation and chemical vapor deposition (CVD) remain the most widely used 
techniques in fabricating CNTs/CNFs due to their ability to synthesis large quantities of the 
CNTs/CNFs. The discovery of CNTs by Iijima was made possible by the arc-discharge 
evaporation method [20]. Since then, several researchers have employed modified methods of this 
process in their approach [45-47]. Even though this method has the advantage of being a simple 
process that produces CNTs/CNFs with excellent crystallinity, its products do suffer from low 
purity [46, 48]. The laser ablation method requires complex and expensive equipment and give a 
limited yield as well [48]. Purification and separation of products from both the arc-discharge and 
laser ablation techniques have negative impact on subsequent use of the CNTs/CNFs. The CVD 
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process is much more amenable to scale-up allowing the fabrication of relatively large amount of 
nanofibers with the least cost. CVDs also enable synthesis to be achieved under relatively mild 
conditions, giving more control over the growth process. This has allowed the growth of aligned 
and ordered CNT/CNF structures in a controllable manner on various surfaces [37, 39, 49, 50]. 
 
Various structures obtained from the CVD synthesis of CNFs have been proposed. However, the 
ability to control and tailor the structure of CNFs demonstrated by Rodriquez et al. [51] is the 
adopted one by most researchers. It involves the creation of a faceted catalyst particle on which 
the carbon feedstock decomposes on certain surfaces with carbon precipitation occurring on the 
remaining surfaces of the catalyst [51, 52]. The conditions of growth favors the formation of 
graphene sheets which grow parallel to the surface of the faceted catalyst particle which in turn 
determines the angle between the planes and the fibril axis [53]. Under different conditions of 
gases and catalyst compositions, and temperature, the faceted catalysts undergo surface 
reconstruction forming unique geometrical shapes which drive the formation of the different CNFs 
structures [51, 54, 55]. The use of acetylene and hydrogen gas mixtures, fabrication temperatures 
around 600 C, and nickel and its alloys as catalysts, have been reported to favor the formation of 
the herringbone structure [51, 52]. The presence of excess hydrogen have been reported to favor 
the termination of the large number of dangling bonds at the edges of the stacked graphene 
platelets, whereas the more stable form of the carbon filament with closed tubular graphene sheets 
and without dangling bonds are favored without hydrogen termination [25, 56]. 
 
The fabricated CNFs appear as powders resembling soot. The individual nanofibers are generally 
combined into aggregates which can often be seen even by the naked eye. They have extraordinary 
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thermal, optical, mechanical and electrical properties. The exploitation of their extraordinary 
electrical and optical properties can be achieved commercially if the nanofibers are applied as 
carbon nanofiber superstructures. This will eliminate the signal fluctuations associated with 
measurements from individual fiber strands and also improve their visibility due to the cluster of 
nanofibers produced. The well-known techniques for consolidating metallic and ceramic particles, 
pressing and sintering, cannot be applied to CNFs. As a result, other methods are being used to 
produce forests of CNTs/CNFs on three dimensional substrates [37-39, 49, 50, 57]. 
 
Successful grafting of CNTs/CNFs forests on the surfaces of spherical substrates have been 
achieved by different researches [37-39, 49, 50, 57]. These spheres provide added advantages in 
that they can be stacked easily while still providing much larger outer surfaces than conventional 
flat wafers while they also have the best fluidity among all shapes of solid particles. Xiang et al. 
[50] successfully used a large-scale production technique to fabricate aligned CNT arrays on 
ceramic spheres comprising of SiO2, Al2O3, and ZrO2. They reported being able to use their 
product in constructing a conducting matrix in a polymer as well as in electromagnetic shielding 
applications. Multi-scale hybrid structures of multi-walled CNTs and micrometric alumina 
particles have also been produced using chemical vapor deposition process with promising 
application in advanced multifunctional composite materials [39]. CNFs on glass microballoons 
(NMBs) have been fabricated by the author in the laboratory and NMBs’ use in syntactic foams 




2.2 Structure of CNF 
The building blocks of both CNF and CNT are the graphene layers. The angle of inclination of 
these layers with respect to the fibril axis differentiates the CNFs from the CNTs. While the CNTs 
have parallel orientation to the fiber axis making them cylindrical, the CNFs are inclined at varying 
angles to the fibril axis. The different inclination angles have led to the discovery of different CNF 
structures. The various identifiable structures of CNFs are shown in Figure 2.1. The chemical 
nature of the catalyst, the conditions of its pretreatment, the composition and flow rate of the gas 
mixture, the duration of the synthesis are properties related to the structure of the CNFs [60-63]. 
The electrical and optical properties are also largely dependent on their structures [40, 64, 65]. 
 
   
(a)  Platelet (b)  Platelet (Spiral) 
(c)  Fishbone hollow 
core 
   
(d) Fishbone solid core (e)  Ribbon (f)  Stacked cup 
Figure 2.1 Schematics of the different structures of CNFs [40]. 
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Platelet CNFs have the graphene layers perpendicular to the fiber axis {Figure 2.1(a)} and with 
fibril widths up to about 100 nm [40]. Platelets do contain non-negligible amounts of hydrogen or 
other heteroatoms for the stabilization of their structure. The catalyst used is usually located in the 
mid portion of the fiber resulting in bidirectional fibers [51, 66]. Coiled structures of these platelets 
have also been reported [67, 68]. CNF structures produced with the graphene layers inclined at 
angles less than 90 to the fiber axis have been identified as fishbone. The inclined angle has been 
reported to depend, among other parameters, on the presence of hydrogen in the feedstock [56]. 
The resulting structures are either hollow core {Figure 2.1(c)} [69] or solid cores {Figure 2.1(d)} 
[51]. The structure of ribbon CNFs and multi-walled carbon nanotubes (MWCNTs) bear striking 
resemblance. The ribbon CNFs {Figure 2.1(e)} comprise of straight unrolled graphene layers 
running parallel to the fiber axis [51]. The cylindrical cross-sections of the MWCNT enables their 
distinction to be made. The last identified structure, stacked cup CNFs, is made up of a spiral 
graphene layer along the fibril axis. They have been reported to have a circular cross-section with 
a huge hollow space [70]. This structure is favored by the use of a molten catalyst [40]. 
 
Despite distinct differences in the internal structures of CNFs and CNTs, the term CNTs are more 
often used to classify CNFs as well since they can display similar morphology to MWCNTs; 
however, their physical and chemical properties are quite different. While CNTs are reported to 
display ballistic electron transport [71] and diamond like tensile strength [41] along their axis, 
CNFs have proven their robustness as individual, freestanding structures with higher chemical 
reactivity and electron transport across their sidewalls. Their high chemical reactivity makes them 
candidate materials for applications such as biosensing which requires selective functionalization 
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and attachment of biological molecules while their outstanding electron transport ability is 
exploited in their use in electrochemical applications.  
 
The graphene sheet is a flat monolayer of carbon atoms packed tightly into a two dimensional and 
crystallizes in a honeycomb lattice. Carbon has an outer shell containing the 2s22p2 orbitals and 
the hexagonal lattice arrangement of the carbon atoms in graphene allows the formation of two 
penetrating sub-lattices, which is a result of its sp2 hybridization [72].  The four valence carbon 
electrons only bonds to three other carbon atoms leaving an unoccupied 2pz orbital perpendicular 
to the plane of the graphene sheet of the valence atomic bonds. Stable sigma bonds between the 
three nearest carbon atoms are formed in the planar orbitals with the remaining free 2pz orbitals 
overlapping between neighboring carbon atoms to form weak pie bonds. These out of plane pie 
bonds are responsible for the excellent electrical properties of the graphene sheets, and hence the 
good conductivities of various CNF structures. The conduction electrons can travel large distances 
without being scattered, that’s up to 25000 cm2 per volt-second, which is only 300 times less than 
the speed of light [73]. The 2.3% cloudiness on the honeycomb graphene surface leaving over 97% 
visual transmission rate gives graphene, and hence CNFs, their extraordinary optical properties 
[74].  
 
The structural configuration of CNFs and their high surface area-to-volume ratios therefore allows 
the confinement of the free pi electrons around the circumference and length of the CNFs. The 
presence of strong covalent and pi bonds and the ability to selectively attach functional groups 
makes these structures ideal for use in a wide range of applications such as in biosensors, 
composite materials, electronic devices, and field emission displays. 
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2.3 Surface Functionalization of CNFs 
All known methods of synthesizing of carbon nanostructures have been reported to generate some 
amount of amorphous carbon and catalyst nanoparticles as impurities in the final product [45-50]. 
Hence contamination and their poor solubility in aqueous media have been their major obstacle to 
their use in biosensors and other applications. The various techniques, for the purification of the 
“as fabricated” carbon nanostructures involve their manipulation into a useful state which consist 
of extensive mechanical and chemical processing. These processes change the surfaces of the 
carbon nanostructures and more often creates isolated point defects or vacancies, topological 
defects, and sp2-sp3 hybridization defects in the hexagon graphene framework. The absence of 
carbon atoms from their original positions as a result of incomplete bonding during synthesis 
results in the introduction of point defects in the structure. The topographical defects are created 
as a result of pentagon and heptagon carbon lattice formation along the carbon nanostructure walls. 
Stone-Wales defects, 2 pentagons and 2 heptagons, have a unique characteristic in adsorption of 
hydrogen and other foreign atoms and this has a potential in applications such as biosensing and 
energy storage. The interaction between the adsorbing hydrogen and carbon atoms during the 
synthesis process also leads to the generation of the hybridization defects [75]. Purification 
techniques leads to the production of cleaner materials as well as the introduction of functional 
groups which makes it easier for further processing of the carbon nanostructures. They however, 
results in partial loss of structure and material as well as increased number of defects on their 
surfaces. 
 
The presence of van der Waals forces in these carbon nanostructures is also responsible for the 
agglomeration of the individual strands in various aqueous media. Due to their smaller sizes, these 
15 
 
van der Waals forces are stronger in carbon nanostructures, requiring the use of functionalization 
techniques to aid and maintain dispersion. With all the carbon nanostructures, the CNFs are less 
affected by the van der Waals forces and tend to stay dispersed for longer periods of time. 
Controlling the surface chemistry of these CNFs is therefore critical to defining their functionality. 
Their surface charge, hydrophobicity, and chemical reactivity can be and have been altered through 
both covalent and non-covalent modifications [62, 76-78]. 
 
Covalent, or chemical attachment of functional groups takes advantage of the higher reactivity of 
carbon atoms at defect sidewalls and the end caps of carbon nanostructures to carry out a series of 
reaction steps. Only a smaller fraction undergoes the functionalization compared to the non-
covalent type. The direct covalent sidewall functionalization is associated with a change of 
hybridization from the sp2 to sp3 losing p-conjugation system on the graphene layer in the process. 
Molecules with higher chemical reactivity are used due to the inert nature of the sidewalls [79].  
 
The use of xanthates in the functionalization process has been reported to offer the advantages of 
easy processing and versatility towards applications in a multitude of domains [80]. Use of other 
molecules such as elemental fluorine in the functionalization of the carbon nanoparticles have 
resulted in weaker C-F bonds which provides substitution sites for additional functionalization 
[81]. Successful replacement of the fluorine atoms by amino, alkyl and hydroxyl groups have been 
achieved [82]. Other methods of sidewall functionalization, including cycloaddition [83], gas-




Functionalization of the defect sites and end caps are achieved by oxidative damage to the 
nanostructure framework by strong acids and oxidants which results in the formation of carboxyl 
acid, ketone, alcohol and ester groups at the sites attacked by the acid. These functional groups 
serve to tether many different types of chemical moieties onto the ends and defect sites of these 
nanostructures. Treatments of carbon nanostructures with strong acids such as HNO3, H2SO4 or a 
mixture of them [86-88], or with strong oxidants such as KMnO4 [89], ozone [90], reactive plasma 
[91] tend to open up these structures with the introduction of the functional groups. These 
functional groups have rich chemistry and have been used for further chemical reactions in 
applications such as biosensing, silanation, and esterification [79, 85, 86]. 
 
Covalent functionalization introduces several polar and non-polar functional groups onto the 
carbon nanostructures making them soluble in various organic and inorganic solvents. Two major 
drawbacks are however associated with these methods. First, ultrasonication and centrifugation 
associated with these methods leads to the creation of large number of defects on the sidewalls, 
and in some cases, fragmentation of the nanostructures into smaller pieces. These damaging effects 
lead to severe degradation in the mechanical properties and the disruption of π electron system. 
Electrical and thermal properties of the structure is subsequently reduced since the defect sites tend 
to scatter the conducting electrons and phonons [92]. The other major drawback is the effect of the 
concentrated acids and strong oxidants on downstream processes. These chemicals are 





An alternative method of tuning the interfacial properties of the hydrophobic carbon 
nanostructures is through the use of non-covalent functionalization. The use of ionic surfactants 
such as sodium dodecyl sulfate (SDS), which is widely used in household products such as 
shampoo and shaving foam, has been found to be of great value in solubilizing CNTs. The ionic 
surfactants operate by transferring a charge to the surfaces of the CNTs. The CNTs are then 
dispersed by electrostatic forces with the behavior of the dispersion showing a strong dependence 
on pH [93]. Non-ionic surfactants, such as triton X-series, have also been used to solubilize CNTs 
in water [94]. These non-ionic surfactants operate using a combination of hydrogen bonding and/or 
steric dispersion forces. At high concentrations, these surfactants form micelles, with the CNTs 
held in the hydrophobic core of the micelles [93]. 
 
The use of relatively small molecules containing planar groups that irreversibly adsorb to the 
nanostructure surfaces by π-stacking forces have also been used. Chen et al. [95] used a planar 
pyrenyl group to non-covalently functionalize the surface of SWCNT. This formed the van der 
Waals bonds and a ‘tail’ consisting of succinimidyl ester group. Finally, helically wrapping the 
tubes with linear polymers such as polyvinylpyrrolidone (PVP) and polyethylene glycols (PEG) 
have also been successfully used. Zhang et al. [96] used PVP to modify the surface of MWCNTs. 
They reported a straightforward and efficient method for dispersing the MWCNTs in water and a 
variety of organic solvents with the solvents being kept for up to 2 months without the MWCNT 
precipitating out. The use of PEG in non-covalently modifying the surface of carbon 




2.4 Experimental Procedures 
2.4.1 Catalyst Coating of Glass Microballoons 
Glass microballoons (MBs), the three dimensional microstructure on which the carbon nanofibers 
were synthesized was purchased from 3M Corporation, USA. They are chemically stable 
lightweight/high strength hollow glass spheres with a soda-lime-borosilicate composition and a 
true density of 0.22 g/cm3. Their diameters range between 5 to 75 µm with their surface amendable 
to treatment with a variety of functional coatings [98]. Electroless deposition (ELD) of nickel on 
the glass microballoons was achieved using the three stage functionalization, activation and 
deposition technique [99]. 3-aminopropyltrimethosxysilane (APTMS), sodium hypophosphite 
(NaH2PO2.H2O), nickel (II) chloride hexahydrate (NiCl2.6H2O), and ammonium chloride (NH4Cl) 
were purchased from Alfa Aesar Chemicals, MA, USA; palladium (II) chloride (PdCl2) from 
Strem Chemicals, Inc., USA; sodium citrate dihydrate (Na3C6H5O7.2H2O) from Mallinckrodt 
Chemicals, Inc.; and ammonium hydroxide solution (NH4OH) obtained from BDH Aristar were 
used in the ELD process. Temperatures for all processes not stated were carried out at 25 C. The 
steps used for Ni deposition are explained in detail below: 
 
 Functionalization 
Glass microballoons (about 10g) were cleaned repeatedly with acetone, isopropyl alcohol, and 
ethanol respectively. The microballoons were filtered from each of the solvents using a vacuum 
assisted set-up. The washed microballoons were then dispersed in 700 ml of ethanol. 
 
The washed microballoon/ethanol solution was placed on a combined hot-plate magnetic-stirrer 
device and vigorously agitated. 1.4 ml of APTMS was added to the suspension and the stirring 
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was allowed to proceed for 2 hours. The functionalized microballoons were washed twice with 
ethanol and filtered using the vacuum assisted set-up. 
 
 Activation 
The functionalized microballoons were transferred to a 700 ml ethanol solution containing 0.14 g 
of PdCl2. The mixture stirred and left to react for 2 hours at room temperature. The activated 
microballoons were then thoroughly cleaned by washing twice with ethanol and deionized water. 
420 ml of deionized water was then added. 
 
 Deposition 
The electroless solution was prepared by dissolving 4.2 g of NiCl2.6H2O, 1.39 g of NaH2PO2.H2O, 
7.0 g of Na3C6H5O7.2H2O, and 6.96 g of NH4Cl in 140 ml of deionized water. The pH of the 
solution was adjusted to 8.30 by adding sufficient amount of NH4OH. This solution was introduced 
into the 420 ml activated microballoons solution and the temperature raised to 90 C. It was 
vigorously stirred and the reaction left to proceed for 15 minutes. 
 
2.4.2 CNF Growth 
An OTF-1200X-80-II-F3LV dual zone tube CVD furnace was used for the CNF growth. This 
process of growth was first reported by Lee et al. [100] and a schematic of the setup is shown in 
Figure 2.2. 20 mg of Ni coated microballoons was uniformly spread on two 40 cm2 silicon wafers. 
The wafers were placed in the second heating zone of the furnace. The temperatures of the CVD 
zones were set at 850 C and 650 C respectively and the furnace programmed to reach these 
temperatures in 40 minutes. An inert atmosphere was maintained in the furnace by flowing 160 
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sccm of Ar gas throughout the fabrication process. The growth was carried out in 15 minutes by 
flowing a mixture of 100 sccm of H2, 30 sccm of C2H2, and 350 sccm of Ar through a deionized 
water maintained at 60 C. After the growth process, the temperatures in the two chambers were 
programmed to attain 100 C in 50 minutes. All gas tank pressures were maintained at 5 psi. 
 
 
Figure 2.2 Schematic of the CVD system. 
 
2.4.3 Surface Functionalization of CNF 
Nitric acid (68% v/v) (HNO3) obtained from Macron Chemicals and H2SO4 (98% v/v) from Fisher 
Scientific were used for the acid functional process. As fabricated NMBs was used for the surface 
modification studies. The carboxyl groups were grafted onto the surface of the as-fabricated NMBs 
Volume Flow Controller 








following modifications of two different acidic processes reported by Osorio et al. [101] and Liang 
et al. [88]. The first method involved the treatment with nitric acid where 2 mg of NMBs was 
refluxed with 2 ml concentrated HNO3 for 24 hours. The second procedure involved the treatment 
10 mg of NMBs with 8 ml 1:3 volume concentrated solution of HNO3/H2SO4 also for 24 hours. 
The resulting NMBs solutions were filtered and washed using distilled water. Both filtrates were 
suspended in 8 M NaoH, obtained from Macron Chemicals, for 24 hours and then filtered. To 
neutralize the filtrates, they were rinsed with dilute HCl, obtained from Macron Chemicals, 
filtered, washed with an excess of distilled water, and then left to dry. 
 
A third and simpler method used to graft carboxyl groups onto the surface of the CNF was 
conducted in the reaction chamber of the CVD equipment. 20 mg of NMBs was heated to 400 C 
in dry air for 30 minutes after which it was allowed to cool. 
 
2.4.4 Characterization 
Scanning electron microscopy (SEM) was carried out to observe the morphology of the four 
different NMBS samples. These are the as fabricated, HNO3 treated, HNO3/H2SO4 treated and air 
oxidized samples. Characterization was performed using an FEI Quanta 3D FEG Dual Beam 
FIB/SEM with an xT Microscope Control Software. Images were recorded with an accelerating 
voltage of 5 kV by placing samples on a double sided copper tape and attaching it to a stand.  
 
The Nicolet 6700 with OMNIC software was used for the Fourier transformed infrared 
spectroscopy (FTIR) characterization to determine the successful carboxyl functionalization of the 
CNFs. Samples were loaded onto an ATR sample holder for analyses. The surface chemical 
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bonding and structure of all four samples analyzed were obtained in the frequency range of 600 – 
4000 cm-1. 
 
The Renishaw 2000 Micro-Raman was used for the Raman studies of the as-fabricated CNF. The 
presence of defective graphitic sheets was obtained in the frequency range of 1000 – 2500 cm-1. 
 
2.5 Results and Discussions 
2.5.1 Catalyst Layer Formation 
The three stage flow mechanism employed for the ELD process is shown in Figure 2.3. The 
functionalization stage introduces the amine group onto the surface of the MBs which is 
subsequently activated by the adsorption of Pd(II). The final deposition results in a color change 
of the glass spheres due to the uniform layer of nickel coating deposited on the glass surface. Figure 
2.4 shows images of MB, nickel coated MB, and NMBs. Figure 2.5 shows an SEM micrograph of 
the nickel coated MB and a typical optical micrograph of the nickel coated MBs formed on silicon 
wafer [102]. The FTIR spectra of as-received MBs and ELD nickel coated MBs are shown in 
Figure 2.6. Similar spectra were obtained for both samples. The spectra composed mainly of the 
broad absorption bands at ~700 – 1000 cm-1 corresponding to the S-O stretching vibrations. The 
bands at ~1405 corresponds to the O-H bends respectively [103]. The peaks at ~2364 cm-1 can be 
associated with the O-H stretch from strongly hydrogen-bonded –COOH [104]. The nickel coating 
therefore did not contribute any functional groups to the surface since they only acted as nucleation 








Figure 2.4 Images of as-received microballoons, microballoons after electroless nickel 








































Figure 2.5 (a) SEM micrograph of nickel coated MBs and (b) typical optical micrograph of a 
layer of nickel coated MBs formed on silicon wafer [102]. 
 
 
Figure 2.6 FTIR spectra of (a) as received MB and (b) nickel coated MB. 
 
Nonmetallic substrates like glass microballoons lack the catalytic properties required for CNF 



























achieved by coating the surface of our glass microballoons with nickel. The presence of hydroxyl 
groups on the surface of glass makes them easily amenable to surface modification. These silanol 
functional groups, Si-OH, bonds strongly with amino groups, such as APTMS, to form the stable 
siloxane bond, Si-O-Si as a result of the partial protonation of the APTMS. This has been reported 
to uniformly coat the surface of the glass while the amine group protrudes outwards serving as 
active sites on the glass surface for binding with other molecules [105, 106]. However, these amine 
groups have low affinity for nickel hence the use of Pd (II) as catalyst. This is reduced by the 
presence of H2PO2
¯ to form Pd which is strongly bonded to underlying siloxane layer. These Pd 
particles act as seeds for the nickel deposition process resulting in the almost uniform nickel 
coating of the surface of the MB.  
 
2.5.2 CNF Growth 
Figure 2.7 shows the SEM micrographs of CNFs grown on the MB at two different magnifications. 
The nickel layer formed on the MB acted as nucleation sites and growth for the CNFs. This ensured 
that the CNFs are connected to the MB along their axial direction, which is essential in building 
efficient charge and load transfer interfaces. The micron dimension of the spheres also allows the 
uniform and randomly oriented growth of several CNFs on each MB as shown in Figure 2.7. 
Average CNF diameters of 40 nm with high CNF density on each MB were fabricated using this 
process. Figure 2.8 shows the Raman spectra of the as fabricated CNFs [102]. Defective graphitic 
sheets are always present in fabricated CNFs and this was confirmed by the D-band observed at 




Figure 2.7 (a), (b) SEM micrographs of as-fabricated NMBs at different magnifications. 
 
 
Figure 2.8 Raman spectra of as-fabricated CNFs [102]. 
 
Gases such as methane, acetylene, xylene, ethylene, and carbon monoxide have all been used in 
the fabrication of CNFs with varying advantages of each of these carbon sources [107]. The use 
of C2H2 as the source of carbon for the growth was chosen due to its higher decomposition rates 

























been reported to suppress the CNF growth due to its enhanced etching effect [107]. The use of 
hydrogen influenced the decomposition of the nickel precursors and C2H2, avoided the formation 
of amorphous carbon on the surface of the nickel catalyst and also acted as a carrier gas. The use 
of water vapor, a weak oxidizer, selectively removed amorphous carbon deposits thereby 
preventing the coating of the catalyst particles and hence improving the CNF growth. Argon gas 
acted as the major carrier gas in the system while maintaining a neutral environment in the chamber 
[108].  
 
From the fabrication parameters, the length of the CNFs, evident in Figure 2.4 (b), curved with 
irregular wave shapes due to the surrounding neighboring particles as the CNF length increased. 
This is consistent with the report published by Zhang et al. regarding the increase of the branched 
length of CNF with growth time progressively in a quasi linear manner [49]. This type of structure, 
compared to the vertically aligned, is more desirable for applications in biosensing devices as more 
outer CNFs surfaces are made available for conjugation with biomolecules which can easily be 
immobilized on capture substrates. 
 
2.5.3 Surface Functionalization Results 
The fabrication process used in CNF growth results in the deposition of varying amounts of 
oxidized carbonaceous fragments. Coupled with the inert nature of the sidewalls of the CNFs, a 
combination of acidic and basic solvents were used in the functionalization of the CNF. The 
schematic modification of the CNF using HNO3 as an example is shown in Figure 2.9. Acidic 
oxidation most often results in the oxidation of the carbonaceous fragments and this was avoided 
by washing with NaOH before oxidizing again with the dilute form of the acid used in oxidation. 
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SEM micrographs of the three oxidation methods used are shown in Figure 2.7 (a) – (d) while the 
combination of acidic effect and the several washing resulting in the fracturing and peeling off of 
the CNFs from the MBs are shown in Figure 2.7 (d). 
 
 
Figure 2.9 The modification process of CNFs by HNO3 treatment. Carbonaceous fragments 
are represented by red wavy lines. Similar processes are found elsewhere [88]. 
 
The acid oxidation is a more selective technique that removes amorphous carbons and contaminant 
metals; however, its effect can be seen in the SEM micrographs. The concentrated nature of these 
acids resulted in the shortening of the CNFs on the MBs and increase number of surface defects 
with the HNO3/H2SO4 combination having the most pronounced effect. This is consistent with 
findings by several researchers [48, 86-88, 109]. The interaction between the graphene layers of 
the CNFs and these concentrated acids have been investigated by Collins [110]. His findings 
indicate that these highly oxidative acids do not continuously etch the graphene’s sidewalls due to 
their inert nature but instead covalently add to its edges and basal planes resulting in adduct defects 
which continuously etch off these planes with time. This is responsible for the loss of structure in 
the acidic functionalization with the stronger HNO3/H2SO4 combination having a more adverse 






Figure 2.10 SEM micrographs of (a) air oxidized, (b) HNO3 oxidized, (c) HNO3/H2SO4, and 
(d) fractured and peeled off CNFs from acidic oxidization of MBs. 
 
Oxidation in air tends to have a harsher purification scheme at temperatures between 400 C and 
750 C. At the low end of this temperature range, amorphous carbon has been reported to rapidly 
convert to CO2 through cooperative reactions with oxygen and water vapor [110]. The graphitic 
carbons do burn more slowly, since only the carbon atoms on the edges of the graphene are 
reactive. Therefore, at 400 C oxidation temperature, the fraction of graphitic impurities on the 
CNFs surfaces will oxidize faster along their sidewalls than the edges of the graphene. This is 
responsible for the better retained structure of the NMBs after oxidation. 
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Figure 2.11 shows the dispersed states of the three different types of oxidized NMBs in water, at 
the moment of dispersion and approximately 2 mins and 10 mins thereafter. When a surface is 
oxidized, ionic charged functional groups are introduction onto its surface. In this study, negatively 
charged carboxyl and hydroxyl groups are chemically introduce onto the surface. These charged 
groups initially enables the CNFs to repel each other in the water solution, and hence their initial 
good dispersion. Suspension stability reduces drastically with time with HNO3 having the worst 
stability among the three groups as shown in Figure 2.11 (b) after only 2 minutes of suspension. 
After 10 minutes, most of the NMBs are seen to settle for both the HNO3/H2SO4 and air oxidized 
with the air oxidized having the better stability. During settling, a portion of the NMBs were seen 
to settle at the bottom of the tube with the remaining floating on the water. 
 
The air oxidized had the best stability with HNO3 oxidized having the worst. However, the long 
term solubility of all oxidized samples was very poor. The difference in solubility can be attributed 
to the efficiency in functionalization with HNO3 having the least number of functionalized groups 
and air oxidized having the most. 
 
Figure 2.12 shows the FTIR spectra of the as fabricated and the three different oxidized NMBs. 
The introduction of the infrared radiation onto the samples led to a difference in charge state 
between the carbon atoms which induced the formation of an electric dipole leading to signal 
generation. The frequency of adsorption is a function of the stretch and bending functional group. 
Weak signals were generated due to the weak difference of charge state between the carbon atoms 
leading to a silent spectrum. All four samples presented similar signals with the exception of the 
~2359 cm-1 peak in the acidic oxidized samples. This peak is from the characteristic disruption of 
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the quaternary ammonium (C=N+) formed as a result of the presence of nitrogen in the fabrication 
environment [111]. The acidic oxidants reacts with this functional group, hence the absence of this 








Figure 2.11 Dispersion of NMBs in PBS after modification with HNO3, HNO3/H2SO4, and air 
(from left to right). All solutions have 1 mg/ml concentration of NMBs and at times (a) just 




Figure 2.12 FTIR Spectra of as-fabricated and the different types of surface oxidized samples 
used in the research. 
 
Weak signals were also generated at ~3666 cm-1 characteristic of stretching vibrations of O-H 
bonds preferentially from the hydroxyl groups. The appearance of peaks at ~1000 – 1100 cm-1 for 
all the samples correspond to the C-O stretching indicating the presence of the carboxyl groups. 
The presence of these functional groups which was confirmed from the FTIR results agrees with 
the observed stability of these samples in water. These functional groups reduced the van der Waals 
interactions between the individual NMBs leading to an improvement in their dispersion stability 
in the aqueous media. 
 
2.6 Summary 
In summary, fabrication of CNFs on glass microballoons has been achieved using a classical CVD 
process. This was made possible by uniformly coating the MBs with nickel using a three stage 




























carbonaceous fragments requires further purification techniques. These techniques result in the 
production of cleaner materials as well as the introduction of functional groups making it easier 
for further processing of the CNFs. FTIR studies showed the presence of the hydroxyl and carboxyl 
functional groups on the as fabricated CNFs. The three different purification methods employed 
in this study also showed the presence of the hydroxyl and carboxyl functional groups. However, 
the acid modified surfaces resulted in the substantial loss of CNF structure while the air oxidized 
NMBs maintained its CNF structure. The other major drawback in the use of the acidic oxidants 
is their effect on downstream processes. These chemicals are not environmentally friendly and 
may affect applications in biosensing and other acid sensitive uses. The air oxidized CNFs 
therefore stands out as the ideal surface treatment method for attaching the hydroxyl and carboxyl 






IMMUNOASSAY ON GLASS SLIDE USING CARBON NANOFIBERS GROWN ON 
GLASS MICROBALLOONS (NMBs) 
 
3.1 Introduction 
Disease diagnostics continues to play a major role in the healthcare sector. It is regarded as an 
attempt at classifying an individual’s condition into separate and distinct categories that allow 
medical decisions about treatment and prognosis to be made. Several methods have been used in 
diagnostics. These methods include clinical, laboratory, radiology, retrospective, and 
immunoassay diagnoses. Technological advances have led to rapid improvements in most of these 
techniques with immunoassays being no exception.  
 
Immunoassays provide quick and accurate tests that are widely used for on-site and laboratory 
diagnosis of various diseases. It is a valuable analytical technique based on molecular recognition 
between antibodies and antigens that allows for detection with high sensitivity and specificity. 
They have been widely used for the identification and quantification of target molecules in 
applications such as clinical diagnostics, proteomics, pharmaceutical research, environmental 
analysis and basic biological investigations [112, 113]. The high specificity of the antibody/antigen 
interaction enables the relevant analyte to be isolated from complex mixtures with minimal sample 
preparation while being relatively inexpensive and providing exceptionally low detection limits 
[113]. 
 
The high specificity of the antibody/antigen interaction makes their immobilization on any support 
a vital process. The ideal support should robustly attach all the chosen biological species in an 
appropriate orientation without altering their conformation. Attachment has been a challenge on 
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different substrates due to the variety in the polarities, hydrophobicities, charges, sizes, and 
structures of different biological species while repelling nonspecific binding. Successful 
immobilizations have however been achieved on substrate materials such as those made from 
silicon, glass, and polymers [12, 114-119]. The need for less sample/reagent consumption, a 
reduced risk of contamination, enhanced sensitivity, low unit cost, lower power consumption, and 
a higher reliability led to the use of microfluidic devices for immobilization [113].  
 
Silicon and polymeric materials such as polydimethylsiloxane (PDMS) are materials commonly 
used for the fabrication of these microfluidic systems. As a result, various protocols have been 
developed for immobilizing various biological species on these substrates. The presence of bubbles 
and dead volumes continue to hinder the full scale utilization of silicon in microfluidic devices. 
With PDMS, hydrophobic surface and nonspecific adsorption of proteins and other molecules have 
constituted their major limitation [118]. The optically transparency of glass throughout the visible 
spectrum, the ability to easily functionalize the surface of glass, and the recent low cost of 
fabricating glass-based microfluidic chips has played a role in its continued use as a substrate in 
immobilization [119]. An added advantage is their ability to offer higher density arrays and the 
use of lower sample volumes. New materials such as paper and cotton thread have recently also 
been introduced as simple and low-cost platforms for immobilizing biological species [112, 120, 
121]. 
 
Labeling biological species has always been a challenge. Labeling on their antigenic epitopes 
result in the loss of their interlocking ability with affinity reagents, hence their structure and label 
location need to be understood. Various labels, including fluorescent substrates, enzymes, redox 
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molecules, and metal/semiconductor particles, are utilized and these play a key role in signal 
generation [122]. Other immunosensors do also employ label-free detection where the amount of 
target antigen is quantified by physical and chemical changes arising from target antigen capture 
on the sensing surface [123]. Sensitive detection still remains one of the main challenges facing 
clinical diagnostics in the early stages of disease. Extensive research on the use of other labels, 
such as CNTs, with better signal detection capabilities is currently ongoing [28-32, 124]. 
 
Physical adsorption and chemical modification are the two strategies used in the application of 
biological species onto various substrates. The physical adsorption (interaction) technique takes 
advantage of non-covalent interactions such as van der Waals forces, hydrogen bonding, and 
hydrophobic interactions between the species and the substrates [125]. The adsorbed species are 
usually randomly oriented, forming a heterogeneous surface, which usually lead to low surface 
density, reduced activity, may prevent analyte binding, and lead to irreproducibility of results. 
Adsorption processes do cause some species also to denature and are subsequently inactive upon 
direct contact with the substrate. Finally, due to the weak attractive forces, attached species may 
easily be washed away during the numerous washing stages and at the same time while also 
causing the reversibility of the adsorption process [126]. 
 
The covalent attachment protocol relies on the formation of covalent bond between a functional 
group on the substrate and an exposed group on the species. The substrates may be functionalized 
with a variety of chemical groups such as NH2
¯, SH¯, COOH¯, NHS ester and epoxide groups 
[127]. Substrates with functional groups such as the amine only adsorb proteins via electrostatic 
interactions but this can be made to change to the aldehyde surface by exposing it to 
37 
 
glutaraldehyde, a crosslinking agent [128]. The presence of these functional groups on all parts of 
the antibody as well makes it easier for covalent bonding to be achieved in a random orientation 
[129]. 
 
3.2 Antibodies as Recognition Elements 
The extraordinary properties of carbon nanomaterials have led to increasing research into their 
possible use in various applications. Investigation into their use in the detection of biomolecules 
and other medical related applications continues to attract a lot more interest [24, 31, 74, 86, 120, 
130]. CNFs in this study are used as labels with the detection mechanism mainly based on the 
antigen-antibody interaction. Since the mid-1990s, antibodies have become an important class of 
drugs, with more than 28 antibodies approved for therapeutic and diagnostic use in the US and 
Europe [131]. Initially, the approved antibodies were based on mouse (immunoglobulin G) IgG or 
chimeric IgG with those based on humanized or fully human IgG sequences entering the market 
most recently. 
 
Immunoglobulin (Ig), also known as antibodies, are large Y-shaped protein produced by B-cells 
that are used by the immune system to identify and neutralize foreign objects such as bacteria and 
viruses. IgG is a major effector molecule and accounts for about 75% of the total Ig in plasma of 
healthy animals including humans. IgM, IgA, IgD and IgE accounts for the remaining 25% with 
each of them having a characteristic property and function. Human IgG has a molecular weight of 
~150 kDa and is secreted by specialized B lymphocytes known as plasma cells. Antibodies display 
an extraordinary specificity and binding affinity for antigens in nature. Each antibody has a unique 
structure recognized by a corresponding antigen in a lock-and-key mechanism. This mechanism 
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makes them useful as analytical reagents in diagnostics, in environmental and food tests, and in 
many other uses [132]. 
 
IgG has a structure made up of three protein domains as shown in Figure 3.1. Two identical 
domains make up the arms of the Y-shape structure and are known as “Fab”, fragment, domains 
in which each arm contains a site that can bind to an antigen, making IgG bivalent molecules. The 
third domain forms the base of the Y-shape and it is known as “Fc”, fragment that crystallizes. 
The Fab segments are linked to the Fc by the hinge region, which varies in length and flexibility 
in the different antibody classes and isotypes [133]. This segment allows lateral and rotational 
movement of the two antigen binding domains. The two heavy-chain polypeptides in the Y 
structure are identical of about 50 kDa, and the carboxyl-terminal regions of the two chain fold 
together to make the Fc domain. The two light chains are also identical with a molecular weight 
of about 25 kDa. All, polypeptide chains are held together by disulfide bridges and non-covalent 
bonds [133]. The presence of several different functional groups on all parts of the antibody makes 
it easier for covalent bonding to be achieved in a random orientation with other substances [129].  
 
Two groups of antibodies, polyclonal and monoclonal, have been classified based on their 
specificity against a given antigen. Polyclonal antibodies are produced by immunizing animals 
such as chicken, mouse or rabbit with an antigen and adjuvant preparation. The animal’s immune 
system is stimulated to produce B cells which secrete antibody that is specific for the antigen. 
These are extracted from the animal antiserum and purified to the desired level. Polyclonal 
antibody are prepared usually by mixing antibodies of different specificities making them bind 
with different strengths to different epitopes on the same antigen. The production process is 
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relatively inexpensive, universal and large quantities of an antibody can be isolated from a single 
extraction. They are able to withstand greater variation in temperature and pH and are used to 
confer passive immunity to certain diseases [134].  
 
 
Figure 3.1 Schematic structure of IgG [135]. 
 
Monoclonal antibodies are identical because they are produced by specialized cells which have 
been cloned. Currently, this type of antibodies is only produced in mice. They are obtained by 
collecting cells from the spleen of a mouse exposed to an antigen. These cells are cultured with 
cells from a myeloma, a cancer of the plasma cells, to create a hybridoma which will endlessly 
replicate itself. Tested cells from the hybridoma with the desired antibodies are cloned and used 
to develop a large store of monoclonal antibodies. These antibodies are pure, making them superior 
to polyclonal antibodies. A powerful feature of monoclonal antibodies is that the immortal nature 
of the hybridoma allows for its continual reculturing, thus providing a constant source of 
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monoclonal antibodies. Monoclonal antibodies bind to only one epitope of a given antigen, being 
more specific than polyclonal antibodies [136]. 
 
3.3 Binding of Antibodies to Carbon Nanofibers 
In order to fully recognize the potential of using CNFs as labels in biosensing devices, it is essential 
to be able to attach biomolecules on to their surfaces. The two most used methods of attachment 
of biological species to CNFs are the adsorption and covalent attachment methods. Physical 
adsorption is the simplest method of binding in which biomolecules are mechanically attached on 
to the surface with the help of van der Waals forces. It involves applying a buffer solution 
containing the biological molecule on to the CNF. Due to the high aspect ratio and the 
hydrophobicity nature of the CNF, the applied biological molecule is easily adsorbed to the CNF. 
Protein surfaces with high degree of hydrophobicity display a stronger affinity to the CNF surface. 
Suresh et al. [137] have reported a high amount of ricin adsorption on MWCNT compared to 
graphite paste electrodes using physical adsorption. 
 
Covalent attachment involves the formation of covalent chemical bonds between the biomolecules 
and the CNFs. The best stability, accessibility and selectivity can be achieved through this type of 
bonding due to its capability of controlling the location of the biomolecules. Chemical bond 
formation requires the reaction between functional groups on the surfaces of both the CNFs and 
the biomolecules. Functionalization of the CNFs is always performed prior to immobilization. The 
carboxyl acid group is often the best choice because it can undergo a variety of reactions and is 
easily formed on carbon nanotubes via oxidizing treatments. The control of reactants and/or 
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reaction conditions may control the locations and density of the carboxyl groups on the nanotubes 
which can be used for controlled attachment of biomolecules. 
 
The presence of large amounts of both amine and carboxyl acid groups on their surface of proteins 
can lead to undesirable side reactions of intermolecular conjugation of proteins and CNFs [138]. 
This intermolecular connection can be avoided by using a two-step process where the carboxyl 
acid groups on the CNFs are first reacted with the water soluble 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC). This converts it to active esters surface 
functionalities and the addition of Nhydroxysulfosuccinimide (sulfo-NHS), another water soluble 
compound, increases the solubility and stability of the intermediate. The resulting product reacts 
with the primary amine functional group on the surfaces of the biomolecules to form very strong 
amide bonds as shown in Figure 3.2 [127]. Thus, the process can guarantee homogenous 
attachment of proteins onto carbon nanotubes. 
 
 
Figure 3.2 Reaction of the carboxylate functional group with a primary amine containing 
molecule, in the presence of EDC and sulfo-NHS [139]. 
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Abera and Choi have reported the covalent immobilization of the protein molecules on MWCNT 
via the two-step EDC and sulfo-NHS coupling chemistry [140]. They chemically bonded human 
IgG to carboxyl acid functionalized MWCNT through the two step coupling chemistry [141]. Their 
process avoided the intermolecular conjugation of proteins, and guaranteed the uniform attachment 
of the IgG on the MWCNT. Lerner et al. have also been able to use the two –step approach to treat 
SWCNT and used the treated CNTs to rapidly detect very low concentrations of Lyme disease 
antigens [142]. Covalent attachments, however, do provide good stability between the antibodies 
and the CNFs and also better binding selectivity due to their ability to directly control the location 
of the antibody [143]. However, their electronic and mechanical properties are negatively affected. 
 
3.4 Blocking as a Means of Preventing Non-Specific Binding 
Biological samples are complex in nature containing numerous types of proteins and other 
molecules. Non-specific binding (NSB) of undesired molecules from a sample is a major obstacle 
in the development of biosensors. NSB becomes a major issue when incorporating carbon 
nanomaterials into biosensors. CNFs have a high chemical affinity for biomolecules and end up 
binding with unwanted molecules as well. As a result, the generated signal are not proportional to 
the analyte concentration. NSB can therefore increase detection limits and degrade sensitivity. 
Minimizing protein NSB have been achieved by using specific molecular receptors. The receptors 
cover the gaps on the CNFs wall left unprotected by the immobilized protein with specific blocking 
agents [141, 144, 145]. 
 
NSB, mainly by the spontaneous adsorption of the protein, to the nanostructure surface is usually 
attributed to hydrophobic interactions between the protein and the nanotube surface. Various 
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surfactants including polyvinylpyrrolidone (PVP), Tween 20 and polyethylene glycol (PEG) have 
been used in reducing this type of NSB. All these three surfactants display protein-resistant 
properties. Successful modification of the surface of MWCNTs has been achieved with PVP 
enabling the uniform dispersion of the MWCNTs in aqueous solutions [141]. Hasan et al. have 
also reported the dramatic improvement in the stability of SWCNT in N-methyl-2-pyrrolidone 
solution by PVP. In addition, their SWCNTs spontaneously debundled some nanotube aggregates, 
increasing the isolated SWCNT population without any further ultrasonic treatment [146]. The 
improvement in the dispersion was attributed to the wrapping and twisting of the PVP polymer 
around the CNT centers through their flexible or semi-flexible backbones [147].  
 
Tween 20 contains a long alkyl chain of twelve carbons with twenty ethylene glycol and three 
terminal hydroxyl groups. It has been reported that a Tween 20 coated semiconducting nanotube 
device did not show any changes in conductance upon exposure to various types and 
concentrations of protein solutions. The surfactant was found to strongly adsorb onto the CNT 
surface forming a nearly uniform layer by favorable hydrophobic interactions which imparted a 
high protein resistance [148]. PEG has also been adsorbed onto the surface of CNTs where it acts 
as an effective barrier against nonspecific protein adsorption by forming a highly hydrophilic, 
neutrally charged, sterically hindering layer at the surface.  
 
Shim et al. (40) found the coadsorption of Triton and PEG on SWCNTs to be highly effective in 
preventing nonspecific adsorption of streptavidin to nanotubes [149]. The adsorption of PEG on 
the surface of MWCNTs has also been reported to improve the dispersion of MWCNTs in aqueous 
solutions [141]. In the case of PEG, the adsorption mechanism of NSB onto the surface of the CNT 
44 
 
is less understood. However, a brush-induced steric repulsion preventing contact between proteins 
and the underlying surface, and the hydration shells around the PEG moieties, has been proposed 
as the dominant mechanism for their adsorption [150]. 
 
3.5 Detection Principle 
3.5.1 Biomolecule – NMBs Conjugation 
The use of both competitive and sandwich protocol in disease detection has been studied. 
Sandwich immunoassay format is preferred in RDTs devices because samples do not have to be 
purified before analysis. The schematic of the fluorescence studies for the sandwich format is 
shown in Figure 3.3. CNFs are grown on glass microballoons (NMBs) and initially conjugated to 
the primary antibodies. The NMBs are further immersed in a solution containing the desired 
antigens. The antigens are interlocked by the primary antibodies after which the NMBs are then 
immersed in a solution containing secondary antibodies coupled to fluorescein isothiocyanate 
isomer I (FITC). Further interlocking between the antigens and the secondary antibodies occur 
leading to the formation of a strong bond between the NMBs and the biomolecules.  
 
 
Figure 3.3 Schematic of the processing stages of a sandwich immunoassay protocol. 
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3.5.2 NMBs Immobilization on Glass Slide 
The schematic of the NMBs immobilization process on glass substrate using the sandwich 
immunoassay protocol is demonstrated in Figure 3.4. The sandwich protocol is used in RDTs due 
to its high specificity resulting from the use of two antibodies [151]. This sandwich protocol is 
also suitable for analyzing complex samples and provides high flexibility and sensitivity. All 
antibodies are designated as Y in Figure 3.4. NMBs {shown in Figure 3.4 (a)} are initially 
conjugated with secondary antibodies {Figure 3.4 (b)}. Primary antibodies, however, are 
immobilized on the capture zone of the glass slide as shown in Figure 3.4 (c). Antigens are locked 
by the immobilized primary antibodies when PBS/antigen suspension was passed through the 
capture zone {Figure 3.4 (d)}. NMBs in Figure 3.4 (b) were then flowed through the capture zone 
in Figure 3.4 (d) with captured antigens interlocking with the secondary antibodies on the NMBs 
as shown in Figure 3.4 (e). 
 
 
Figure 3.4 Schematic of the capture procedure of NMBs on glass slide. (a) NMBs, (b) 
secondary anti-IgG conjugated NMBs, (c) primary IgG immobilized on glass slide, (d) anti-IgG 
locked by immobilized primary IgG, (e) immobilized NMBs on slide, and (f) signal detection 
setup. 
 
The binding of primary and secondary antibodies with antigens gives a visibly dark signal at the 
capture zone. Electrical resistivity measurements can be conducted at the capture zone {Figure 3.4 
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(f)} and the generated electrical signal will vary with the antigen concentration. Increasing the 
antigen concentrations will result in increasing density of NMBs being immobilized at the capture 
zone as depicted in Figure 3.5. As a result, the capture zone becomes darker while the resistivity 
of the zone reduces accordingly. 
 
 
Figure 3.5 Schematic of increasing anti-IgG concentrations on NMBs network at the capture 
zone. 
 
3.6 Experimental Procedures 
Air oxidized NMBs samples were used for all tests. 4-morpholinoeethanesulfonic acid (MES) and 
polyethylene glycol solution (PEG) (MW 8000) purchased from Sigma-Aldrich, GA, USA and 
phosphate buffered saline 1X solution (PBS), 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide 
hydrochloride (EDC) and N-hydroxysulfosuccinimide (Sulfo-NHS) obtained from Thermo Fisher 
Scientific, IL, USA were used in the immobilization process. Fluorescein isothiocyanate isomer I 
(FITC), purified immunoglobulin G (IgG, 4.7 mg/ml) from human serum, anti-human IgG (10.2 
mg/ml) antibody produced in goat, anti-goat IgG-FITC (15.4 mg/ml) produced in rabbit, and 
sodium borohydride were obtained from Sigma-Aldrich, MO, USA. All biomolecule contained 
samples were obtained in a solution of 0.01 M PBS, pH 7.4 and containing 15 mM of sodium 





PEG was used as the surfactant for non-covalent functionalization of the NMBs in this study. Its 
use has been reported to prevent NSB [140]. For all blocking procedures, 2 mg of NMBs was 
dissolved in 5 ml of PEG and 5 ml of PBS. The suspension was mildly swirled for 6 hours. Dilution 
with PBS, centrifugation at 2000 rpm for 3 minutes and subsequent filtration were performed to 
obtain the PEG covered NMBs filtrate. Further washing with PBS was done to completely remove 
all unbound PEG. The PEG coating prevents nonspecific binding (NSB) of unwanted proteins to 
the NMBs. 
 
3.6.2 Functionalization of NMBs with EDC/Sulfo-NHS 
The covalent immobilization of the biomolecules to the carboxyl groups of the NMBs was 
performed using a modified EDC/Sulfo-NHS chemistry [141]. 5 ml, pH 6.0 solution of 0.2 M EDC 
and 0.1 M Sulfo-NHS was prepared in MES solution. 2 mg of NMBs were suspended in the 
prepared solution. The suspension was mildly agitated for 2 hours at room temperature. The 
carboxylated CNFs on the microballoons reacted with the EDC/Sulfo-NHS solution forming a 
semi-stable amine-reactive Sulfo-NHS ester. The reaction process is shown in Figure 3.2. The 
NMBs were recovered by centrifuging at 2000 rpm for 3 minutes followed by filtration. MES was 
added and the centrifugation and filtration process repeated three times. This completely removes 
excess EDC/Sulfo-NHS from the NMBs. 
 
3.6.3 Biomolecule – NMBs Conjugation 
Various protocols were studied using the fluorescence test. Firstly, the binding of both antigens 
and antibodies tagged with FITC to NMBs were performed. Secondly, non-covalent 
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functionalization with PEG was performed before the conjugation of NMBs to antibodies. Thirdly, 
NSB was studied by conjugating excess anti-IgG to PEG treated NMBs. The filtrate was treated 
further with anti-IgG-FITC. Competitive assay format was also tested. IgG conjugated to NMBs 
was treated with anti-IgG-FITC. Finally, sandwich assay format was performed by treating IgG 
conjugated to NMBs with anti-IgG.  
 
The sandwich conjugation of antigens to the EDC/Sulfo-NHS treated NMBs samples was achieved 
by adding a solution containing 1 ml of PBS and 100 µl of anti-IgG. The mixture was incubated 
at room temperature and mildly agitated for 24 hours. Excess reactants were removed by washing 
with PBS as described earlier. This conjugates primary IgG to the NMBs. PBS (1 ml) and anti-
IgG (100 µl of 1 ng/ml) was added to the NMBs that contains immobilized primary IgG and 
incubated for 24 hours at room temperature to bind the anti-IgG with the IgG. Thorough washing 
with PBS was performed to remove all unbound anti-IgG. The filtrate was again dissolved in 1 ml 
PBS and 100 µl of secondary IgG-FITC. The solution was incubated at room temperature and 
mildly swirled for 24 hours. Unbound IgG-FITC was removed by washing with PBS. The 
sandwich interlocking of the IgG with anti-IgG was confirmed from fluorescence studies. 
 
The effect of IgG concentration on its conjugation with NMBs was studied using four different 
IgG concentrations. 1.6 mg of EDC/Sulfo-NHS treated NMBs dissolved in 5 ml of PBS was 
prepared. To each solution, 20 µl of 0.001 ng/ml, 0.01 ng/ml, 1 ng/ml, and 10 ng/ml of IgG-FITC 
was added. The solutions were left to stand for 24 hours after which they were centrifuged and 
filtered. Three separate washings were performed on these samples using PBS and the obtained 
filtrates used for fluorescence studies. Similar test was carried out using anti-IgG-FITC. 
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3.6.4 Preparation of Immunosensor 
Micro-glass slides used for the fabrication of the immunosensor were obtained from Corning, NY, 
USA. Tween-20 purchased from Amresco, OH, USA, NaOH and H2O2 from Macron Chemicals, 
PA, USA, and H2SO4 from Fisher Scientific, USA were used in the cleaning process. Anhydrous 
toluene solution from Macron Chemicals, PA, USA, glutaraldehyde obtained from Sigma-Aldrich, 
MO, USA, and 3-aminopropyltriethoxysilane (APTES) from Alfa Aesar Chemicals, MA, USA 
were used in the amino functionalization of the glass slides. 
 
Glass preparation and cleanliness are of critical importance in antibody immobilization. Glass 
slides were cut into rectangular shapes (1 cm × 2.5 cm) and capture zones marked within the mid 
portion of the slides. The slides were ultrasonicated in deionized water containing 2% Tween-20 
by volume for an hour. The washed slides were thoroughly flushed in deionized water and 
ultrasonicated again for an hour. 
 
Surface modification of the glass with APTES reported by Tang et al. [115] and Tsutsumi et al 
[116] were modified to suit our process. Slides were initially soaked in 1 M NaOH for 30 mins 
and then rinsed with deionized water. Washed slides were soaked in piranha solution, 30% H2O2 
and 70% H2SO4, at 80 C for 2 hours. They were thoroughly washed with deionized water, 
followed by ethanol and acetone and dried for an hour at 110 C. The piranha solution roughens 
the surface of the slides for subsequent immobilization procedures. Modification by immersing 
slides in 5% APTES in anhydrous toluene solution for 10 mins proceeded immediately resulting 
in the formation of amino groups on the surface of the glass slides. The slides were thoroughly 
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rinsed with toluene and acetone before drying at 110 C for an hour. This removed completely 
excess APTES and toluene solution. 
 
Activation of the amino functionalized slide surfaces was achieved by immersing the slides in a 
3% glutaraldehyde in PBS solution for an hour. The slides were thoroughly rinsed with ethanol 
and deionized water to completely remove unreacted glutaraldehyde. Nitrogen gas was used to dry 
the slides. Two treated slides were used for the immobilization processes. A solution made up of 
50 µl of 1 mg/ml human IgG and 20 µl of glycerol was prepared and spotted on the capture zones 
of both slides. The slides were left to incubate for an hour after which they were thoroughly washed 
with PBS to remove unbound IgG. The slides were incubated in a 2% BSA and 0.05% Tween-20 
in PBS solution for an hour. This blocks all sites from nonspecific binding. Slides were thoroughly 
washed with 0.05% Tween-20 in PBS. 
 
50 µl of 0.01 ng/ml of anti-IgG in PBS was applied onto the capture zone of the first slide. The 
anti-IgG is expected to be captured by the immobilized human IgG on the slides. The slide was 
allowed to incubate for 30 seconds after which it was thoroughly rinsed in PBS solution. 1 mg of 
IgG conjugated NMBs were then suspended in 5 ml PBS solution. Both slides were dipped in the 
NMBs/PBS solution for 30 seconds. The slides were carefully rinsed with PBS solution. 
Immobilization of NMBs using anti-IgG concentrations of 0.1, 0.5, 1, 5, 10 and 50 ng/ml were 
also studied. The presence of visible NMBs at the capture zones of the slides indicates the 





Same treatment procedure was used for the immobilization of the NMBs on the glass slides. 
 
3.6.5 Imaging 
Scanning electron microscope (SEM) micrographs were obtained using an FEI Quanta 3D FEG 
Dual Beam FIB/SEM and its xT Microscope Control Software. 
 
Fluorescence studies was performed on samples using a Leica DM RXA2 fluorescence microscope 
fitted with a 100× objective lens with a 1.4 N.A. Slidebook version 4.1 was used for image 
acquisition from a Cooke SensiCam QE camera attached to the microscope. The FITC used in the 
study incorporate excitation filters in the green (530 to 565 nm) spectral regions allowing the 
detection of green emissions. 
 
Optical images were obtained from an Axiovert 40 CFL inverted microscope fitted with a 20× 
objective with a 1.0 N.A. AxioVision 4.6.1.0 was used for image acquisition from an AxioCam 
MRc camera attached to the microscope. 
 
Percentage area occupied by the NMBs on the glass slides were obtained using ImageJ 1.46r 
software. 
 
3.6.6 Electrical Measurements 
A Lucas Labs Pro-4 four point resistivity system was used in obtaining resistivity measurements. 
The system is made up of a Keithley 2400, a Pro4 and a notebook with a Pro4 V1.2.4 software 
installed. The system uses the dual configuration test method of ASTM standard F84-99 to 
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compensate for errors in probe spacing and errors caused by proximity to the edge of the 
conducting layer. A V/I measurement was taken and recorded and the subsequent resistivity 
computed. 
 
3.7 Results and Discussion 
3.7.1 EDC/Sulfo-NHS Functionalized NMBs 
The use of EDC reagent acts as a crosslinker for the terminal –COOH groups on the ends of the 
CNFs on the NMBs. This forms an inefficient amine reactive O-acylisourea intermediate that 
dissociates rapidly regeneration of the carboxyl group. This makes it unstable and short-lived in 
aqueous solutions. The addition of sulfo-NHS, in a two-step crosslinking procedure, results in the 
formation of the semi-stable amine-reactive sulfo-NHS ester. This intermediate has sufficient 
stability and bonds with the amine groups on proteins to form a very strong and stable amide bond 
[152]. This reaction allows the carboxyl groups on proteins to remain unaltered [153]. 
 
The FTIR spectrum from the EDC/Sulfo NHIS treated NMBs show three additional peaks 
compared to that of the as-fabricated. The spectra are shown in Figure 3.6. There was a weak signal 
from the O-H stretching at ~2104 cm-1. A broader peak was created at 3100 – 3600 cm-1 and this 
is attributed to vibrations of the hydroxyl (O=C-OH and C-OH) group [104]. The third peak 
observed between 1470 – 1735 cm-1 is associated with the two amide bands of the semi-stable 
intermediate. The amide band I is located at 1650 cm-1 (80% C=O stretch), the amide band II at 
1550 cm-1 (60% N-H bend and 40% C-N stretch [103, 154]. The appearance of the amide bands I 
and II indicates the successful functionalization of the carboxylated CNFs with the semi-stable 




Figure 3.6 FTIR spectra of EDC/Sulfo NHS treated NMBs. 
 
3.7.2 Non-Specific Binding 
Proteins are made up of 20 amino acids groups that are either hydrophilic or hydrophobic, acidic 
or basic in nature. This gives proteins a broader diversity in properties with each protein having 
different individual functionalities [155]. As a result, proteins are physically and chemically 
heterogeneous making them possess a three-dimensional structure that is critical to their function. 
Proteins lose activity when they bound to solid surfaces and have been reported to absorb 
nonspecifically to each other, to substrate materials, and to other proteins [156]. The variety of 
polarities, hydrophobicities, charges, sizes, and structures, of proteins poses a challenge when 
attaching different types of proteins to various substrates. This makes it difficult to achieve both 




























The stability of CNFs in buffer solutions and the elimination of NSB are critical prerequisites for 
their use in biosensing applications. Results from this study show that a coating of PEG on the 
NMBs reduces the duration for the particles to cluster {Figure 3.7} compared to that for the air 
oxidized NMBs samples shown in Figure 2.11. The PEG chain completely wraps around the CNF 
surface leading to its hydrophilic chaining extending into the aqueous phase, imparting water 
solubility and biocompatibility. The presence of the hollow glass microballoons are responsible 
for the eventual coalescence of the NMBs with time. Treatment with PEG also led to the saturation 
of the free binding sites on the CNFs which resulted in the reduction of non-specific binding in 
our study. 
 
   
Figure 3.7 Dispersion of NMBs in PEG solution at times (a) just dispersed, (b) 10 minutes, 
and (c) 20 minutes. 
 
Figure 3.8 shows fluorescence micrographs of anti-IgG-FITC bound to NMBs (a) without PEG 
and (b) with PEG. The covalent binding between the CNFs and proteins allowed for high stringent 
binding conditions allowing weakly bound proteins to be washed away during subsequent 
processes. Observance of fluorescence showed the successful conjugation of both IgG and anti-
IgG to the NMBs.  
 
(a) (b) (c) 
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PEG treated NMBs initially bound to excess anti-IgG and further conjugation with anti-IgG-FITC 
showed no fluorescence { Figure 3.8 (c)}. This shows the achievement of complete passivation in 
the use of PEG. Treating our NMBs with PEG will eliminate NSB in our conjugation process. The 
use of lower molecular weight PEG (below 5000 Da) have been reported not to efficiently prevent 
non-specific protein adsorption, while longer linear PEG (molecular weights greater than 5000 





Figure 3.8 Fluorescence micrographs of anti-IgG-FITC bound to NMBs (a) without PEG and 
(b) with PEG. (c) Fluorescence micrograph of PEG treated NMBs initially conjugated with excess 
anti-IgG followed by treatment with anti-IgG-FITC. 
 
The FTIR spectra of the NMBs coated PEG is shown in Figure 3.9. The spectra has similar peaks 







broader peak is observed from 870 to 1130 cm-1 after the PEG treatment. Within this wavelength 
region, strong C-O and Si-O stretching vibrations have been reported between 1000 to 1200 cm-1 
[103, 158]. This region comprises of the typical vibration band of –Si-O-Si– at 1110 cm-1 and the 
absorption band at 1115 cm-1 attributed to the characteristic –C-O-C– stretching vibration of the 
repeated -O-CH2-CH2- units of the PEG backbone. Characteristic bands of the crystalline phase of 
PEG have also been reported to be centered at 963 and 843 cm-1 [158]. The presence of this peak 
indicating the functional groups associated with PEG further confirms the successful 
functionalization of the NMBs with the NMBs. 
 
 
Figure 3.9 FTIR spectra of PEG modified EDC/Sulfo NHS treated NMBs. 
 
3.7.3 Conjugation of Biomolecules to NMBs 
Immunoassay is a laboratory technique that uses antibodies to capture molecules of the antigen 




























antigen concentrations in solution. Antigens that undergo this protocol usually have smaller sizes. 
The small molecules have insufficient binding sites and are therefore unable to bind to two separate 
antibodies. No secondary antibodies are used. Instead, a capture antibody is attached beforehand 
to the surfaces of the immobilization material. Antigen (analyte) and a separate antigen molecules 
conjugated to a label compete for the available antibody sites. The material is washed to remove 
all unbound analyte and conjugate and substrate added. For enzyme labels, bound enzyme present 
reacts with the substrate yielding color which inversely proportional to the concentration of the 
analyte in the sample. 
 
Other competitive assay formats have been used where antigen is initially immobilized on solid 
material and antibody conjugated with label material introduced. For enzymatic labels, substrates 
are added and captured conjugates yield color which are linearly proportional to the concentration 
of the captured conjugates. 
 
The use of NMBs as label in a competitive immunoassay protocol was performed. IgG was first 
immobilized on NMBs. Treatment of the NMBs with varying concentrations of anti-IgG-FITC 
was studied with the fluorescence microscope. Fluorescence was not observed in the sample 
treated with 2 pg/ml of anti-IgG-FITC. The interlocking of the IgG with anti-IgG for the remaining 
three samples was confirmed with fluorescence images being generated for those samples {Figure 
3.10}. Similar studies was performed on NMBs conjugated with anti-IgG treated with varying 
concentration of IgG-FITC. Fluorescence imaging indicated successful interlocking of IgG with 




The competitive interlocking of anti-IgG and anti-IgG-FITC with IgG was also studied. Varying 
the anti-IgG concentrations led to fluorescence being observed on samples treated with 0.01 ng/ml 
and 1 ng/ml of anti-IgG {shown in Figure 3.12 (a) and (b)}. No fluorescence was observed on the 
NMBs sample treated with 50 ng/ml of anti-IgG. Low concentrations of the anti-IgG led to fewer 
interlocking with the primary IgG. Free IgG were therefore still available for binding. Addition of 
the anti-IgG-FITC resulted in their equivalent number being able to bind with the available free 
IgG. As the concentration of the anti-IgG increases, the number of free IgG reduces to a point were 
all free IgG get consumed. Absence of free IgG leads to the washing off of anti-IgG-FITC, which 
indicates no bonding and hence the absence in the fluorescence imaging for higher concentrations 
(as shown in Figure 3.12 (c)). 
 
   
Figure 3.10 Fluorescence micrographs of NMBs conjugated with IgG and further treated with 
(a) 0.01 ng/ml, (b) 1 ng/ml, and (c) 10 ng/ml of anti-IgG-FITC.  
 
   
Figure 3.11 Fluorescence micrographs of NMBs conjugated with anti-IgG and further treated 
with (a) 0.01 ng/ml, (b) 1 ng/ml, and (c) 10 ng/ml of IgG-FITC. 
 
(a) (b) (c) 
(a) (b) (c) 
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The sandwich protocol is a more efficient method of sample antigen detection. Samples do not 
have to be purified before analysis while providing relatively higher sensitivity in comparison with 
the competitive format. This method quantifies antigens between two layers of antibodies (i.e. 
capture and detection antibody). The antigen must contain at least two antigenic epitope capable 
of binding to antibody. Either monoclonal or polyclonal antibodies are used. The monoclonal 
antibodies recognize a single epitope and allows fine detection and quantification of small 
differences in antigen. Polyclonal, on the other hand, is used as the capture antibody to pull down 




Figure 3.12 Fluorescence micrographs of NMBs conjugated with IgG. The NMBs were then 
treated with varying anti-IgG concentrations followed by anti-IgG-FITC (a) 0.01 ng/ml, (b) 1 





The use of NMBs as label in a sandwich immunoassay protocol was performed. Monoclonal and 
polyclonal IgG and anti-IgG were used. Successful interlocking of the biomolecules was observed 
from the fluorescence imaging as shown in Figure 3.13.  
 
 
Figure 3.13. Fluorescence micrograph showing sandwich conjugation of IgG/anti-IgG/IgG-
FITC on NMBs. 
 
3.7.4 Immunosensor 
Various sensing mechanisms are being used in immunosensors. The use of CNTs/CNFs allow 
sensing to be achieved through optical and/or electrical means with several demonstrations been 
reported [30-32, 78, 138, 141, 142, 159, 160]. The electrochemical methods are highly attractive 
due to their simplicity and relative ease of calibration while allowing quantification to be made 
[159]. Currently, optical sensing is the only method being used in RDTs. This study demonstrates 
the use of both optical and electrical sensing in RDTS.  
 
Plain glass slides have been reported to exhibit a high degree of protein immobilization [161]. The 
cleaning and roughening of the glass slides prior to any biological immobilization process is a 
necessary step in getting rid of all residual organic contaminants which would otherwise interfere 
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with the subsequent silanization procedure. The use of piranha solution in the cleaning process, in 
our case, has been reported to introduce hydrophilicity to the surface of the glass slides as well as 
maximizing the number of carboxyl groups [162].  
 
Biomolecules are very diverse in nature possessing several carboxyl and amine groups. The use of 
competitive immunoassays techniques in immobilizing biomolecules onto glass substrates poses 
a great challenge. This technique permits signal amplification, however, recognition antigens that 
are in low abundance must compete with more abundant proteins for immobilization on the glass 
substrates. The sandwich format differs by being highly specific while permitting cross reactivity 
of the antigens with two different antibodies. This makes them ideal formats for detecting disease 
causing antigens and has therefore been adopted for use in RDTs devices.  
 
Sandwich immobilization of NMBs on glass slide was achieved by using primary IgG, secondary 
IgG labeled with NMBs and varying concentrations of 0.002, 0.004, 0.006, 0.008, 0.01, 0.1, 0.5, 
1, 5, 10 and 50 ng/ml of anti-IgG. Successful detection of anti-IgG on the capture zones of the 
glass slides were achieved within one minute. This was detected by observing visible network of 
NMBs on the capture zone {Figure 3.14}. Increasing the anti-IgG concentration increased the 
density of the NMBs as depicted in the optical micrographs shown in Figure 3.15 for some anti-
IgG concentrations. A linear relationship between the number of immobilized NMBs and anti-IgG 










Figure 3.15 Optical micrographs showing NMBs captured on glass slides in a sandwich assay 








Figure 3.16 Variation of percent area of the capture zone covered with NMBs against anti-IgG 
concentrations. 
 
The use of the four-point probe method for electrical measurements helps in eliminating the 
impedance contribution of the wiring and contact resistances. In this study, the use of CNTs as 
label in the detection of anti-IgG was also performed. That allowed comparison to be made 
between CNTs and NMBs labels under same conditions. The resistance measurements of 
immobilized CNTs and NMBs as separate labels at the capture zone was performed. A plot of the 
resistance measurements obtained against concentration of anti-IgG is shown in Figure 3.17. As 
can be observed in Figure 3.17, continuous decline in the resistance within the capture zone was 
observed when the zone was exposed to an increasing anti-IgG concentrations. This pattern was 
observed for both CNT and NMBs labels and was attributed to the formation of interconnecting 
conducting pathway due to the capture of more CNTs/CNFs. The network of NMBs formed were 
more visible even at low anti-IgG concentrations compared to those formed by the CNTs. 
Electrical resistance of the capture zone also reduced drastically as shown in Figure 3.17.  

































Figure 3.17 Variation of the resistance of the capture zone with anti-IgG concentration for 
immobilized NMBs and CNTs. 
 
At anti-IgG concentration of 0.002 ng/ml, the resistivity obtained was the same as that of the plain 
glass. Change in resistivity was first observed when a concentration of 0.004 ng/ml anti-IgG was 
used for NMBs immobilization. This set a detection limit for our immunosensor. At anti-IgG 
concentrations above 5 ng/ml resistivity gradually started to reach a plateau. At higher 
concentrations, (> 10 ng/ml) saturation occurred. Hence, further increases in the number of 
captured NMBs did not result in any significant changes in the resistivity. These measurements 
formed the basis for the quantification of our immunosensor.  
 
As shown in Figure 3.17, the change in measured resistivity was amplified when NMBs were used 
as labels compared to CNTs. This makes NMBs very sensitive to detection of the slightest changes 




















the CNTs. Below this limit, all measurements were approximately equal to the that of the untreated 
glass slides. Hence, NMBs have a far lower detection limit compare with that of CNTs. This 
comparable low detection limit was attributed to the several millions of CNFs on a glass 
microballoon. This gives NMBs better control, larger surface area and higher probability of capture 
of biomolecules. 
 
The NSB of NMBs to the capture zone was also tested to check for the possibility of false alarm. 
No NMBs were observed on the capture zone in the absence of anti-IgG. The resistance 
measurement of the NSB test was obtained to be 8.74 × 1010 Ω-cm which is comparable to the 
9.30 × 1010 Ω-cm obtained for the glass slide. Resistance changes can therefore be attributed to 
the change in concentration of anti-IgG. The successful elimination of NSB reduces the generation 
of false positives and hence minimization of false alarms of the sensor. 
 
3.8 Summary 
The successful immobilization of biomolecules on NMBs fabricated in the laboratory was 
demonstrated in this study. This was achieved through the use of competitive and sandwich 
immunoassay protocols and the results confirmed through fluorescence studies. The fluorescence 
results paved the way for studies into the potential use of NMBs as ultra-low detection labels in 
RDTs. Using glass slide as a substrate and antibody conjugated NMBs as labels, various 
concentrations of anti-IgG have been immobilized. The density of the immobilized NMBs network 
formed varies with the concentration of anti-IgG detected. This network generates both 
colorimetric and conductimetric signaling which relates to the amount of anti-IgG detected. Both 
signals generated are inexpensive, simple, and dependable.  
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Substituting NMBs with CNTs for the anti-IgG detection generated weaker signals. This can be 
attributed to signals being generated from fewer CNTs compared to the several millions of CNFs 
found on each glass microballoons. Therefore NMBs provide better ease of handling while 
offering a higher sensitivity of detection compared to the CNTs.  
 
NMBs can therefore be utilized to achieve ultra-low detection limit in RDTs. Integration of 
millions of carbon nanofibers arranged on such micro-particles provided a higher probability of 
detecting minute concentrations of antigen in analyte. The NMBs also offered significantly higher 
level of sensitivity, as well as, simple and fast visual and/or electrical identification as labels in 
RDTs. It also has an added advantaged of eliminating false-alarms while reducing the incubation 









Rapid immunoassay test configuration use antibodies (Ab) to react with antigens and have been 
developed using a monoclonal – polyclonal (MoAb-PoAb) sandwich assay format. This format is 
well suited for use in malaria and pregnancy test kits. The primary MoAb is bound to solid 
substrates. Positive samples are introduced and react with immobilized MoAb. The flow rate of 
the excess fluids are controlled and channeled to a non-reactive part of the substrate. Secondary 
PoAb and labeling conjugate are then reacted and results obtained a few minutes thereafter [163]. 
This flow through mode of testing utilizes a disposable plastic cassette or strip. This type of test 
requires little sample processing, is cheaper, and generates a yes/no answer without the use of an 
instrument. However, they are not as sensitive as chemical chromatographic methods [164].  
 
Sensitivity is a measure of the reproducibility of sample data from various measurements. This is 
affected by both the uniformity of the test and the analyst’s technique. It is measured by conducting 
several analyses of a sample or a control sample and calculating the relative standard deviation 
[165]. As with all bioassays, the inherent variability between replicate measurements makes it 
necessary to validate most immunoassays tests against their gold-standards. This validation 
eliminates the possibility of presenting both false positive and false negative results [164]. Control 
tests are incorporated to validate the accuracy of the immunoassay tests. Malaria and pregnancy 




Malaria is the most significant tropical disease known to man. It is estimated that 3.3 billion people 
(living in 107 countries), almost half of the world’s population (as shown in Figure 4.1), live in 
areas where malaria transmission occurs [166]. Approximately 300 to 500 million cases of clinical 
malaria occur each year with about 90% of all malaria deaths occurring in sub-Saharan Africa 
[166, 167]. Malaria is spreading as a result of environmental degradation, civil disturbances, 
misplaced populations, increasing travel and drug resistance [168]. Children have been the most 
affected due to their vulnerability to infection. One in every 5 infant deaths is attributed to malaria 
[169]. The disease is preventable and curable. As such, various organizations continue to invest 
resources in its management. 
 
 
Figure 4.1 Global distribution of malaria endemicity [170]. 
 
Rapid and accurate malaria diagnosis is therefore essential to the management of the infection in 
the affected communities [169]. The gold-standard for malaria treatment still remains the 
microscopic examination of blood; thick and thin stains [171]. Research into antigen detection and 
molecular detection assays are also on the rise. These methods are used as alternatives to the 
traditional microscopy method. Subjective diagnosis have also been used in low resource settings 
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for early treatment of malaria. However, malaria rapid diagnostic test kits (MRDTs) have a much 
greater potential of reaching most affected population due to their low cost, simplicity, rapid, ultra 
sensitivity and selectivity of identifying Plasmodium species. 
 
Pregnancy on another hand is a clinical condition that involves the fertilization and development 
of an embryo in a woman’s uterus [172]. On average, a pregnancy with a single embryo lasts 40 
weeks from the first day of the last menstrual period. Most women are anxious to know the start 
of their pregnancy, whereas it may provide a health risk for others and as such needs an early 
diagnosis. Pregnancy diagnosis requires a multifaceted approach using three tools. These 
approaches involve the history and physical examination, ultrasonography, and laboratory 
evaluation [173]. The woman’s menstrual pattern gives healthcare providers an idea of an early 
pregnancy. Physical examination are then carried out to determine enlarged uterus, breast changes, 
and softening and enlargement of the cervix to confirm or dispel the pregnancy diagnosis [174]. 
Ultrasound-based diagnostic imaging technique is also used to confirm a normal pregnancy and 
the age of a baby. It is usually done 12 weeks after the first day of the last menstrual period. 
 
Laboratory diagnostic involves the measuring and monitoring of the quantity of human chorionic 
gonadotropin (hCG). The hCG levels increases significantly after fertilization. The four assays 
used for hCG determination are the radioimmunoassay, immunoaradiometric assay, enzyme-
linked immunosorbent assay and fluoroimmunoassay. These assays are highly specific for hCG 
with antibodies directed against 2 or more isotopes on the intact hCG molecule. Blood and urine 
samples are used for analyses. Urine devices are formulated to detect hyperglycosylated hCG, the 




Malaria infection is caused by the Plasmodium parasites. Plasmodium is a one-cell organism which 
spread in humans through infected mosquito bites and during blood transfusion. The female 
Anopheles mosquito bite is responsible for the spread. The bite is necessary to support the 
nurturing of her eggs [166]. More than 100 different species of Plasmodium exist and have been 
reported to produce malaria in many types of animals and birds, as well as in humans [167]. Four 
of the Plasmodium species that commonly affect humans are the P. falciparium, P. vivax, P. ovale, 
and P. malariae [169]. 
 
The bite of the female Anopheles mosquitoes leads to the feeding of malaria causing parasite 
(called sporozoites) into the blood stream of humans. The four different species of Plasmodium 
have similar life cycle with minor variation. The general life cycle is shown in Figure 4.2. The 
sporozoites travel to the liver and invade the liver cells. They grow, divide, and produce tens of 
thousands of a different form of sporozoites called the merozoites in each liver. Majority of the 
merozoites then exit the liver cells into the bloodstream infecting the red blood cells (RBCs) in the 
process. The minority of merozoites remain dormant in the liver causing relapses weeks or month 
later. The merozoites multiply inside the RBCs, break open within 1 – 3 days, and infect more 
RBCs. This results in several thousands of parasite-infected RBCs in the bloodstream [167]. 
 
Malaria symptoms occur a few days after an infective mosquito bite. This period, known as 
incubation period, varies between 7 to 30 days. The variation of the incubation periods depends 
on the type of Plasmodium parasite. P. falciparum symptoms occurs early with the less deadly P. 
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malariae symptoms occurring after longer incubation periods [169]. Symptoms occur in cycles of 
48 to 72 hours coinciding with the bursting of infected RBCs [167]. 
 
 
Figure 4.2 The life cycle of the malaria parasite [167]. 
 
The initial malaria attack lasts for 6 – 10 hours. It consists of a cold stage (sensation of cold and 
shivering), a hot stage (fever, headaches, vomiting, and seizures in young children), and a sweating 
stage (sweats, return to normal temperature, and tiredness) [169]. In malaria prone regions, 
residents often recognize these initial signs. They begin treatment with on-the-shelf medications 




The type of Plasmodium species infection determines the extent of the malaria attack. Symptoms 
from P. malariae are hardly observed due to the low level of parasitemia produced. P. vivax and 
P. ovale infections only show symptoms between attacks. The paroxysms subside within a few 
weeks even without treatment. P. vivax and P. ovale are able to infect only young RBCs. Hence 
the number of parasites in the blood does not reach the same high levels as observed for the P. 
falciparum infection. The body is able to develop antibodies over time subsiding the infection even 
without treatment. P. falciparum infected individuals may feel miserable even between attacks and 
may lead to death if treatment is delayed. The severity of this attack is due to the ability of the P. 
falciparum parasites to infect RBCs in all stages of their development. Very high levels of 
parasitemia are present in the blood resulting in severe symptoms only after a few days [169]. 
 
P. falciparum parasites are mainly found in tropical parts of Africa and are responsible for the 
severe complications reported. Serious complications observed include cerebral malaria (abnormal 
behavior, impairment of consciousness, seizures, coma, or neurologic abnormalities), severe 
anemia due to hemolysis (destruction of RBCs), hemoglobinuria (hemoglobin in the urine), rupture 
of the spleen, acute respiratory distress syndrome (ARDS) (an inflammatory reaction in the lungs 
that inhibits oxygen exchange), abnormalities in blood coagulation, low blood pressure caused by 
cardiovascular collapse, acute kidney failure, and hypoglycemia (low blood glucose) [169, 170]. 
 
4.3 Diagnosis of Malaria 
Rapid and precise diagnosis of malaria is integral to the appropriate treatment of affected 
individuals. This also prevents the further spread of infection in the community. In low resource 
settings, clinical features of malaria are not specific and presumptive diagnosis is generally used. 
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Healthcare professions use symptoms and physical findings at examination to predict the presence 
of the disease. This presumptive diagnosis is not reliable. The designs of more reliable clinical 
algorithms have helped to accurately diagnose malaria. The designs include microscopy, 
immunology, molecular, and serology [169]. 
 
4.3.1 Microscopy 
Microscopy is an established and relatively simple technique that is familiar to most laboratory 
technicians. This approach remains the gold standard for laboratory confirmation of malaria 
because of its sensitivity, specificity, and ability to quantify the parasitemia level [175-177]. 
However, it is labor intensive and time consuming [178]. The limitation of this method arises when 
mixed infections are present at low parasitemia levels. Highly trained personnel are also required 
in the use of the microscopes as well as in sample preparation. There are two main types of sample 
preparation for the microscopy test: thin and thick films malaria smear methods. Sensitivity and 
selectivity are adequately accommodated using the thick and thin films malaria smears, 
respectively. 
 
In thick film smear, the RBCs are approximately 6 – 20 layers thick resulting in a larger volume 
of blood being used and ability to detect very low parasitemia. As few as 5 parasites/µl of blood 
can be determined [179]. Thick film is used to determine the presence of parasites. In examining 
the thick blood films, the RBCs are lysed (destroyed) making it difficult to differentiate between 
the various Plasmodium species. In thin films, the RBCs are fixed so the morphology of the 
parasitized cells is easily seen. Species identification is clearly made based on the size and shape 
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of the various stages of growth of the parasites. The presence of stippling (bright red dots) and 
fimbriation (ragged ends) are also clearly seen [180].  
 
4.3.2 Molecular 
The use of molecular methods has been reported to yield higher sensitivity, detect mixed 
infections, and to accurately identify Plasmodium species [177, 178, 181]. However, all the 
methods that rely on this method are relatively expensive and require a specialized laboratory 
setup. The results are also not available quickly enough to be of value in establishing the diagnosis 
of a malaria infection. Therefore, molecular tests are used as complementary tools for the diagnosis 
of malaria in some reference laboratories to accurately diagnosis low parasitemia infected patients 
[177]. While this methodology is unlikely to be useful at the peripheral level of healthcare, it may 
have a place as a research tool to monitor malaria control programs. 
 
The molecular diagnostic tests include polymerase chain reaction (PCR), loop-mediated 
isothermal amplification (LAMP), mass spectrometry (MS), and flow cytometric (FCM) assay 
techniques. PCR-based techniques are used extensively to confirm malaria infection, follow-up 
therapeutic response, and identify drug resistance [182]. High cost has limited its use in low-
resource settings. The LAMP method is relatively easier, sensitive, quick, and cheaper than PCR. 
However, its reagents require cold storage, and further trails are needed to validate its feasibility 
and clinical utility [183]. MS has been reported to be rapid, high throughput, and can be automated 
[184]. FCM has the advantage of diagnosing clinically unsuspected malaria. The disadvantages of 
the MS and FCM techniques are their costly diagnostic equipment, labor intensive, and the need 




The diagnosis of malaria using the serological methods is mostly based on the detection of 
antibodies against the macrogametocytes and microgametocytes malaria parasites. The main use 
of this method is for retrospective studies, particularly for epidemiological purposes and for tracing 
asymptomatic infections in blood donors. The various serological tests include 
immunofluorescence antibody test (IFA), enzyme-linked immunosorbent assay (ELISA), 
radioimmunoassays, latex agglutination, indirect haemagglutination, and solid-phase dipstick and 
membrane dot-blot. 
 
The IFA test is the main method for routine serology testing. It is relatively easy to setup and 
highly sensitive and specific [185]. This serological method is not widely used for malaria 
diagnosis because it is time consuming and cannot be automated limiting the number of sera that 
can be studied daily. IFA requires the use of a fluorescence microscope and trained technicians.  
Readings obtained from testing are subjective based on the level of training of the technician. 
Finally, the method is highly labor-intensive limiting its application to specialized centers [184].  
 
4.3.4 Antigen Detection 
Malaria antigen detection tests assist in the diagnosis of infection by providing evidence of the 
presence of malaria parasites in human blood. They are commercially available and allow the rapid 
diagnosis by individuals who are not otherwise skilled in traditional laboratory techniques. 
Antigen-based malaria rapid diagnostic tests (MRDTs) are also cost effective, accurate and find 
widespread use in low resource settings where traditional equipment are not available [184]. 
Currently, over 100 commercially available MRDTS have been approved by the World Health 
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Organization [186]. These MRDTs are based on a lateral flow ‘immunochromatographic’ 
(dipstick), cassette, or card formats [169]. Although MRDTs are supposed to be rapid, it takes at 
least 15 minutes for results to be displayed. BinaxNow has been reported as the fastest MRDT on 
the market with an incubation period of 15 minutes [187, 188].  
 
MRDTs are all based on the same principle: capturing of P. falciparum on a first band, all other 
Plasmodium species on a second band, and a control on a third band of a nitrocellulose strip. A 
lyzing agent is used for rapturing the RBCs. This makes available all merozoites available for 
conjugation with immobilized antibodies.  
 
MRDT performance for diagnosis has been reported to be excellent in several publications [182, 
184, 186, 189-193]. However, several issues remain to be addressed. These include improving 
their accuracy; lowering their cost; improving their detection time and ensuring their adequate 
performance under adverse field conditions. The MRDTs may also not able to detect some 
infections with lower numbers of malaria parasites circulating in the patient’s bloodstream. 
MRDTs are also not able to differentiate between P. vivax, P. malariae and P. ovale. The use of 
dyes as labels have also been reported to negatively impact on MRDTs [194]. These dyes readily 
or continually undergoes chemical, physical, or biological breakdown and may not be available 
for the reaction when needed. Researches into the use of other diagnostic methods are ongoing to 





Pregnancy is a clinical condition that occurs between the conception and birth of a baby. Human 
chorionic gonadotropin (hCG) is a critical hormone whose presence in humans can be used as a 
marker for various aspects of human health. It is used as a biomarker for pregnancy detection, 
gestational trophoblastic disease (GTD), germ cell tumors and some non-trophoblastic 
gynecological cancers and common epithelial tumors [195-197]. Detection and quantification of 
this hormone are essential during pregnancy as it gives valuable information concerning the 
progress of a pregnancy.  
 
hCG is a 37 kDa glycoprotein hormone composed of two dissimilar subunits joined non-covalently 
[198]. These subunits are termed alpha and beta. Common hCG-related molecules in serum 
samples include the regular hCG, hyperglycosylated hCG, nickel hCG, hCG missing the beta-
subunit C-terminal extension, free alpha-subunit, free beta-subunit (hCGβ), free beta-subunit 
missing the C-terminal extension, hyperglycosylated free beta-subunit (hCGβcf) and nickel free 
beta-subunit [196]. The same molecules and the beta-core fragment are present in urine samples. 
 
During the early stage of conception, hCG hormone has the crucial role of maintaining the essential 
steroid production ensuring that the pregnancy progresses unabated. An increase in the 
concentration of hCG and its subunits becomes pronounced when the fertilized egg attaches to the 
wall of the uterus. This occurrence takes a minimum of six days after fertilization [199]. These 
initial concentrations are difficult to detect. However, the amount of this hormone doubles every 
two or three days increasing the probability of its detection with increasing length of the pregnancy. 
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Hence, most commercially available RDTs are able to correctly detect its presence only after high 
concentrations of the hormone are produced. 
 
4.5 Diagnosis of Pregnancy 
hCG is found in both serum and urine of all humans with only a slight concentrations difference 
observed with age and sex. The upper reference limit in serum for men has been reported as 2.1 
pmol/l and in non-pregnant women as 8.6 pmol/l [200]. The upper limit of hCG in the urine of 
men below 50 years is 2.9 pmol/l and 8.4 pmol/l for those older than 50 years. The corresponding 
values for non-pregnant women are 8.8 and 11.5 pmol/l, respectively. 
 
The increase in hCG and its subunits is nearly exponential during the first 5 weeks after ovulation 
[201]. hCGβcf can be detected in serum during pregnancy in quantities corresponding to 0.03% of 
the hCG content. The concentration in urine is about 4000 times more than found in serum [202]. 
hCGβcf is the major form of hCG immunoreactivity in pregnancy urine except during the first 
month of pregnancy, when hCG predominates [203]. The concentrations of hCG immunoreactivity 
in paired serum and urine samples are similar and correlate strongly [204]. Total hCG 
immunoreactivity is higher in urine and apparently attributable to hCGβcf [200]. 
 
Specific measurement of hCG and its directives in serum became possible with the development 
of ultrasensitive immunometric assays that were based on monoclonal antibodies [205]. RDTs are 




4.6 Experimental Procedures 
4.6.1 Reagents and Materials 
As-grown and functionalized NMBs were used for the study. Plasmodium falciparum histidine 
rich protein-2 (PfHRP-2) antigen, Plasmodium vivax merozoites surface protein-1 (PvMSP-1) 
antigen, mouse monoclonal to PvMSP1 antibody (Ms-MAbv), rabbit polyclonal to PvMSP1 
antibody (Rb-PAbv), mouse monoclonal to PfHRP-2 antibody (Ms-MAbf), and rabbit polyclonal 
to PfHRP-2 antibody (Rb-PAbf) were obtained from MyBioSource Inc., USA. hCG, mouse 
monoclonal to hCG (Ms-hCG), and rabbit polyclonal to hCG (Rb-hCG) were also purchased from 
Abcam, USA. All biological samples were obtained in a PBS solution, pH 7.4, and containing 
0.1% of sodium azide. 
 
4.6.2 NMB-Plasmodium Species Conjugation 
CNFs have very high chemical affinity for biospecies [206]. A two-step reaction approach 
described in Section 3.6.3 was used in preparing the NMBs for covalent conjugation with Rb-
PAbf, Rb-PAbv, and Rb-hCG. This reaction forms an ester intermediate on the NMBs that aids 
the amidation reaction. The amidation reaction involves the reaction of the intermediate with the 
primary amine group on the surfaces of Rb-PAbf. Same procedure was followed for the covalent 
conjugation of NMBs with Rb-PAbv, and Rb-hCG. Very strong amide bonds were formed in each 
of the processes [127]. PEG was then applied forming a polyethylene oxide coating on NMBs. 




4.6.3 Preparation of Glass Substrate 
Single and double capture zones marked on several slides were used for the study. Slides were 
thoroughly cleaned, modified, and activated with amino functional groups as described previously. 
All capture zones were treated to prevent NSB with unwanted proteins. Details of immobilization 
Ms-MAbf, Ms-MAbv, and Ms-hCG on glass slides to capture PfHRP-2, PvMSP-1, and hCG 
respectively based on sandwich immunoassay protocol is described in Section 3.6.4.  
 
First, Ms-MAbf was immobilized on glass slides with single capture zone marks. The capture zone 
was used for sandwich immunoassay investigation of PfHRP-2 with concentrations in the linear 
range of 0.01 ng/ml and 10 ng/ml. Similarly, Ms-hCG immobilized on other single marked capture 
zone slides was used to investigate the capture of hCG in the linear range of 0.025 ng/ml and 10 
ng/ml. The visual and electrical detection limits of the PfHRP-2 and hCG were determined within 
their specific ranges.  
 
Second, for the glass slides with double capture zones, Ms-MAbf were immobilized on the first 
capture zone and Ms-MAbv on the second capture zone. Same immunoassay procedure was then 
executed. For performance evaluation, PfHRP-2 was caught at the first capture zone. Experiment 
was repeated using PvMSP-1 sample in PBS with concentrations ranging from 0.01 ng/ml to 10 
ng/ml. PvMSP-1 was caught at the second capture zone and the detection limits of PvMSP-1 in 
PBS solution was obtained. 
 
Third, solutions made up of equal amounts of PfHRP-2 and PvMSP-1 samples were also prepared. 
Concentrations in the range of 0.01 ng/ml and 10 ng/ml for both antigens were used for the study. 
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Similarly, it was observed that PfHRP-2 was caught at the first capture zone and PvMSP-1 at the 
second capture zone. This allows the identification of both antigens from the same mixed sample. 
Scanning electron microscopy (SEM), optical microscopy, and electrical resistivity 
characterization were performed. The procedure and equipment for the characterization was 
reported in the previous chapter. 
 
4.6.4 Characterization 
The morphology of the Plasmodium species was studied using an Olympus CH Binocular 
microscope fitted with a 100× objective with a 1.25 N.A.  
 
4.7 Results and Discussion 
4.7.1 Principle of Disease Detection 
Most MRDTs currently employ the immunochromatographic strip assay technique. This technique 
allows for separation and identification of soluble antigens in solution using complementary 
antibodies. The technique allows for mass production of kits, which in turn allows lower 
manufacturing and distribution cost, and a simplified supply chain. The strip assay technique also 
allows for easy training of users, standardization of result interpretation, and ease of use in 
countries or regions where multiple languages are spoken [207].  
 
Similarly, the NMBs detection technique is based on the immunochromatography sandwich 
approach. As a result of specific binding between the capture antibody and antigen, visible signal 
is generated from the NMBs conjugated with secondary antibody. The optical signal is assessed 
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using the naked eye and quantified using a reading device. Immobilized NMBs on the capture zone 
can also be quantified using the change in electrical resistivity of that capture zone. 
 
The success of the sandwich immunoassay test requires the use of an antigen large enough to 
contain at least two epitopes [165]. PfHRP-2, which satisfies this requirement, has two epitopes 
specific to Ms-MAbf and Rb-PAbf. The primary monoclonal antibody, Ms-MAbf, was 
immobilized on the capture zone of the glass slide as shown in Figure 4.3 (a). PfHRP-2 in PBS 
was applied to the sample pad of the strip. Extra PBS was introduced and acts as a lysing agent to 
improve the sample flow to the absorption pad. The sample mixture migrated across the membrane 
to the capture zone, where Ms-MAbf immobilized on the strip surface captured most of the PfHRP-
2 present in the mixture. The absorption pad regulated the flow and collected all excess fluid. A 
second liquid specimen of the secondary polyclonal antibodies, Rb-PAbf, coupled to NMBs in 
PBS was applied to the sample pad. The Rb-PAbf and NMBs conjugate bind to different epitopes 
on the captured PfHRP-2 antigens. As a result, the Rb-PAbf and NMBs conjugate captured by the 
PfHRP-2 generated a dark line at the capture zone, giving a positive test result shown in Figure 
4.3 (b). Electrical resistivity of the capture zone can also be obtained {Figure 4.3(b)}. 
 
4.7.2 Detection Limit of PfHRP-2 Assay 
Successful immobilization of NMBs on the capture zone of the glass slide was achieved within 
one minute. NMBs were observed to form an interconnecting network at the capture zone as shown 
in Figure 4.4. This network confirmed the detection of PfHRP-2 by the sandwich 
immunochromatography method. Increasing PfHRP-2 concentration increased the density of the 
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immobilized NMB network at the capture zone. This is depicted in Figure 4.4 for four different 









Figure 4.3 (a) Schematic illustration of the sandwich immunochromatographic set-up used to 
detect PfHRP-2 and (b) Illustration of the two different types of signal generation from the 
immunosensor. The yellow cable is used for electrical measurements. 
 
The network of immobilized NMBs at the capture zone for the various PfHRP-2 concentrations 
were characterized. A linear relationship between the percentage area covered by the NMBs (Apct) 
at the capture zone and the concentration of PfHRP-2 in the range of 0.01 ng/ml to 10 ng/ml was 
attained {shown in Table 4.1 and Figure 4.5 (a)}. The correlation equation, 𝐴𝑝𝑐𝑡 = 0.7212 +
1.286𝑥 (𝑅2 = 0.9968) was used, where x is the concentration of PfHRP-2. With high coefficient 
Rb-PAbf 
PfHRP-2 















of determination, this equation can be used to estimate the concentration of Plasmodium 
falciparum in any sample tested. The visual detection limit of the assay was obtained to be 0.025 





Figure 4.4 Optical micrographs showing NMBs captured on glass slides in a sandwich assay 
format with (a) 0.025, (b) 0.1, (c) 1, and (d) 10 ng/ml concentrations of PfHRP-2. 
 








0.025 0.52 0.13 
0.05 0.62 0.33 
0.1 0.75 0.43 
1.0 2.56 0.37 









Figure 4.5 (a) Variation of percent area of the capture zone covered with NMBs against 
PfHRP-2 concentrations and (b) Variation of the resistivity of the capture zone with immobilized 
PfHRP-2 concentration. The error bars in both graphs each shows the variation of five 
concentration points. 
 























































The lowest detection limit of PfHRP-2 reported in the literature to date using immunoassay 
technique has been 0.36 ng/ml [208]. The ultra-low visual detection limit of 0.025 ng/ml obtained 
from this study is attributed to the following. First, the high aspect ratio of CNFs makes available 
several binding sites for covalent bonding with Rb-MAbf. The high aspect ratio arises from the 
construction of the CNFs giving them length-to-diameter ratio of up to 132,000,000:1. This high 
ratio gives CNFs extensive area on their length for several of the nanosized antigens to be 
immobilized. Second, the exploitation of the high chemical reactivity of CNFs with antibodies of 
PfHRP-2 and organic surfactants make it possible for CNFs to be highly selective and specific in 
aqueous environment. Third, large effective surface area remains available on each 
microstructured NMB allowing it to be treated with several millions of PfHRP-2 antibodies. 
Finally, the microstructure of the NMBs allows visual signal amplification and hence easier 
quantification. 
 
Signal detection and quantification of this immunosensor can also be achieved using electrical 
measurement. The high conducting nature of CNFs [59] provides the flexibility to perform 
resistivity changes on the capture zone of the immunosensor in addition to the visual 
characterization. The interconnected pathway formed by the immobilized NMBs at the capture 
zone allowed for an effective electron transfer to be established with the electrode. The resistivity 
of the capture zone was measured at different PfHRP-2 concentrations as shown in Figure 4.5(b) 
and Table 4.2. The higher the concentration of PfHRP-2, the higher was the density of the 
immobilized NMBs and hence the more the CNFs available for conduction. Resistivity of the plain 
glass slide used for the study was obtained as 9.30 × 1010 Ω-cm. Resistivity measurement was also 
conducted in NSB case and it was measured as 8.99 × 1010 Ω-cm. Appreciable change/reduction 
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in resistivity was only observed for concentrations of PfHRP-2 0.01 ng/ml and greater. This set a 
limit of detection for PfHRP-2 as 0.01 ng/ml, which is considered very low. 
 








0.025 4.39E+10 7.50E+09 
0.05 3.57E+10 1.78E+10 
0.1 1.13E+10 2.89E+09 
1.0 4.02E+08 4.31E+08 
10.0 2.46E+06 3.63E+06 
 
 
4.7.3 Selectivity of the PfHRP-2 Detection Assay 
The selectivity performance of the proposed method was also established. In order to determine 
this capability, two capture zones were identified on the immunosensor. On the first capture zone, 
primary antibodies specific to PfHRP-2 were immobilized. Antibodies specific to PvMSP-1 were 
immobilized on the second capture zone. Using the same method as described earlier, the technique 
was able to capture different densities of NMB networks on the first zone when varying 
concentrations of PfHRP-2 in PBS solution was applied on the sample pad. Figure 4.6 (a) shows 
the immunosensor for the detection of 10 ng/ml of PfHRP-2 in PBS solution. Quantification of the 
percent area covered by captured NMBs showed similar pattern to the graph displayed in Figure 
4.5 (a). During the tests with various concentrations of PfHRP-2, no NMBs were observed at the 
second capture zone. 
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Figure 4.6 Glass slides showing (a) visual signal obtained at the first capture zone from the 
detection of PfHRP-2 in PBS solution, (b) signal observed at the second capture zone from the 
detection of PvMSP-1 in solution, and (c) signals obtained at the PfHRP-2 and PvMSP-1 capture 
zones from a mixed PfHRP-2 and PvMSP-1 solution. 
 
The assays with varying concentration of PvMSP-1 in PBS showed a colored signal only at the 
second capture zone. Figure 4.6 (b) shows the immunosensor for the detection of 10 ng/ml of 
PvMSP-1 in PBS solution. Both optical and electrical characterizations were performed on the 
captured NMB network at the second capture zone. Similar to the microscopic characterization of 
PfHRP-2, a linear relationship between Apct at the capture zone and concentrations of PvMSP-1 
was obtained {shown in Figure 4.7 (a) and Table 4.3}. The correlation equation was 𝐴𝑝𝑐𝑡 =
0.6133 + 2.1059𝑥 (𝑅2 = 0.9902). Likewise, R2 has a good correlation and can be used to 
estimate the concentration of Plasmodium vivax in any sample tested. The visual detection limit 
of the assay was obtained to be 0.025 ng/ml. The lowest detection limit of PvMSP-1 reported in 
the literature using immunoassay technique is 6.3 ng/ml [209]. The limit of detection using 
electrical measurements for the detection of PvMSP-1 was obtained at 0.02 ng/ml {Figure 4.7 (b) 
and Table 4.4}. 
 
In another set of tests, a solution containing equal concentrations of PfHRP-2 and PvMSP-1 in 
PBS was prepared. The concentration of both antigens used for the study ranged from 0.025 ng/ml 
to 10 ng/ml. In all the tests performed, NMBs were observed to be captured selectively on both 








Figure 4.7 (a) Variation of percent area of the capture zone covered with NMBs against 
PvMSP-1 concentrations and (b) Variation of the resistivity of the capture zone with immobilized 
PvMSP-1 concentration. 




























































0.025 0.53 0.11 
0.05 0.75 0.11 
0.1 0.93 0.13 
1.0 2.70 0.19 
10.0 21.67 1.09 
 








0.02 6.30E+10 1.82E+10 
0.025 4.32E+10 3.22E+09 
0.05 1.41E+10 4.28E+09 
0.1 9.91E+09 1.80E+09 
0.5 2.20E+09 8.29E+08 
1.0 3.95E+08 3.40E+07 
 
4.7.4 Selectivity of the hCG Detection Assay 
hCG, the clinical condition responsible for the diagnosis of pregnancy, was also tested using the 
immunochromatographic approach as described previously. Ms-hCG was initially immobilized on 
the glass substrates with Rb-hCG conjugated to the NMBs. Varying the concentration of hCG in 
PBS, different densities of NMB networks were immobilized on the capture zone. The correlation 
equation of Apct = 0.4596 + 1.6452x (R
2 = 0.9838) was obtained after optical characterization of 
the NMB networks. This linear relationship is shown in Table 4.5 and Figure 4.8 (a). The visual 
detection limit of the assay was obtained as 0.05 ng/ml. The lowest detection limit of hCG reported 
in the literature using immunoassay technique is 0.5 ng/ml [210]. The limit of detection using 












0.05 0.43 0.15 
0.10 0.72 0.14 
0.50 1.33 0.18 




Figure 4.8 (a) Variation of percent area of the capture zone covered with NMBs against hCG 
concentrations and (b) Variation of the resistivity of the capture zone with immobilized hCG 
concentration. 











































Concentration of hCG, ng/ml
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0.025 6.17E+10 2.29E+10 
0.05 6.50E+10 1.26E+10 
0.1 3.55E+10 8.77E+09 
0.5 5.90E+09 1.11E+09 
1.0 1.67E+09 6.75E+08 
 
4.8 Summary 
The higher probability of capture available to biological species on the novel NMB particles made 
it possible for the immunochromatographic sandwich approach to be used in diagnosing various 
clinical conditions. hCG, the hormone used in the detection of pregnancy was tested. P. 
falciparium and P. vivax, the two most deadly parasites responsible for the majority of severe 
malaria cases were also detected in this study. Ultra-low visual detection limits were obtained for 
all three clinical conditions studied. The method was rapid with detection being achieved within 
one minute of testing. The approach was also able to selectively capture the required antigen at 
different capture zones within the immunosensor.  
 
This unbeatable simplicity, speed of the technique, specific, and ultrasensitive approach makes the 
process very selective with a potential for establishing a visual quantitative relationship for varying 
antigens concentration. Further validation and quantification of results were achieved by 
measuring the change in resistivity within the capture zone. Compared with RDTs which required 
the addition of dyes and enzymatic substrates to the detection solution, the 
immunochromatographic sensor proposed in this work avoided the limitations resulting from the 
requirement of these substrates. The immunosensor exhibited a reliable accuracy and proved to be 
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practical and convenient. This method highlights the potential strategy that can be substituted in 






CONCLUSIONS AND FUTURE WORK 
 
5.1 Conclusions 
5.1.1 Surface Functionalization of NMBs 
Carbon nanofibers (CNFs) were grown on nickel coated glass microballoons (NMBs) using the 
dual zone chemical vapor deposition (CVD) technique. The growth process deposited residual 
amorphous carbonaceous fragments on the NMBs. The amorphous carbon was removed through 
surface functionalization. The surface functionalization resulted in the production of cleaner 
NMBs and also the formation of carboxyl and hydroxyl functional groups on the surface of the 
NMBS. Functionalization was carried out in nitric acid, nitric/sulfuric acid, and air oxidized 
environments. The acidic modified NMBs led to substantial loss of CNF structure while the air 
oxidized process maintained the CNF structure. Acidic treated NMBs were also found to 
negatively impact on biological species and hence not suitable for use in biosensors. Air oxidized 
NMBs therefore stands out as the ideal surface treatment approach. 
 
The air oxidized NMBs preserved their structure and were able to maintain good dispersion in 
water for two minutes. Suspension stability was observed to reduce drastically with nitric acid 
having the weakest stability and air oxidized the best among the nitric, nitric/sulfuric acid and air 
oxidized methods. Reduction in suspension stability occurs by dispersed NMBs coalescing at the 
bottom of the containers while the remaining NMBs float on the water surface. The floating NMBs 
were due to the hollow nature of the microballoons. Air oxidation also introduces carboxyl and 
hydroxyl functional groups to the surface of the NMBs. FTIR studies confirmed the presence of 
the carboxyl and hydroxyl groups. These functional groups are needed for conjugation with 
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biological species in biosensors. Hence, NMBs with the potential of improving the performance 
of rapid diagnostics test kits (RDTs) was successfully fabricated and functionalized. 
 
5.1.2 Conjugation of Biological Species to NMBs 
The integration of millions of CNFs arranged on such micro-particle provided a higher probability 
of attaching several millions of biological species to the NMBs. The ability of CNFs to form 
countless combination and derivatives was exploited to develop next generation sensors. 
Biological species were covalently bonded to the CNFs through an amidation process by taking 
advantage of the EDC/Sulfo-NHS activation method. Non-covalent bonding of PEG to the NMBs 
was also accomplished. The PEG organic molecules covered the sidewalls of the CNFs providing 
a nano-scale coating that led to the prevention of non-specific binding during the sensing 
application. 
 
Competitive and sandwich immunoassay formats were demonstrated using IgG and anti-IgG and 
the results confirmed through fluorescence studies. The fluorescence results paved the way for 
studies into the potential use of NMBs as ultra-low detection labels in RDTs. Using glass slide as 
a substrate and antibody conjugated NMBs as labels, various concentrations of anti-IgG were 
immobilized. The density of the immobilized NMBs network formed varies with the concentration 
of anti-IgG detected. Electrical resistivity measurements of the test zone showed the potential for 
establishing a quantitative relationship for the antigen concentration. Ultra-low detection limit of 
4 pg/ml was obtained from electrical signaling. Visual detection was also achieved due to the dark 
nature of the NMBs at the capture zone. As low as 0.1 ng/ml of anti-IgG were observed with the 
unaided eye at the test zone. The NMBs offered significantly higher level of sensitivity, as well as, 
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simple and fast visual and/or electrical identification of IgG/anti-IgG on the test glass slides. This 
novel approach holds the promise for early detection of various diseases, as well as providing 
healthcare professionals with information regarding the stage of infection. Utilizing this type of 
label could also lead to the elimination of false-alarms while reducing the incubation period 
required for detection in currently used RDTs. 
 
5.1.3 Pathogen Detection on Immunochromatographic Device 
The methodology developed for fabricating, functionalizing and conjugating of NMBs with 
biological species was applied in detecting two major clinical conditions. P. falciparium and P. 
vivax, the two most deadly parasites responsible for the majority of severe malaria cases, were 
detected in this study using the immunochromatographic sandwich approach. P. falciparum 
histidine rich protein-2 (PfHRP-2) and P. vivax merozoites surface protein-1 (PvMSP-1) antigens 
were tested over their linear range of 0.01 – 10 ng/ml. The approach was ultrasensitive and highly 
selective with visual detection limit of 0.025 ng/ml obtained for both PfHRP-2 and PvMSP-1 in 
PBS at two different test zones on the same glass slide achieving multiple disease detection. 
Electrical detection limits were measured as 0.01 ng/ml for PfHRP-2 and 0.02 ng/ml for PvMSP-
1. hCG, the clinical condition responsible for the diagnosis of pregnancy, was also tested at a linear 
range of 0.025 – 10 ng/ml. Visual detection limit of 0.05 ng/ml and an electrical detection limit of 
0.025 ng/ml were obtained. The ultra-low limits obtained for both visual and electrical detection 
for the two clinical conditions have never been achieved using RDTs in the field nor in the lab as 




The use of WAG RDTs avoided the limitations commonly encountered from the use of dyes and 
enzymatic substrates in RDTs. This detection process is reliably accurate, practical and convenient. 
Thus, the highly reactive, rapid, selective and signal amplification capabilities of NMBs is a 
promising tool for use in MRDTs and pregnancy test kits for the early diagnosis of these clinical 
conditions. 
 
5.2 Future Work 
5.2.1 Pathogen Detection in Microfluidic Device 
The developed immunochromatographic device (WAG RDT) in this study was able to effectively 
detect ultra-low concentrations of antigen within a minute of analysis. However, all the reagents 
integral to the process are expensive and therefore miniaturization will reduce the cost and 
efficiency drastically. Miniaturization can be achieved by using a microfluidic immunosensing 
device. Microfluidic devices consist of microchannels for transporting fluids, with part or all of 
the necessary components of the immunoassay procedure integrated in the device [211]. A 
microfluidic device reduce diffusional distances limiting analysis time and enabling more rapid, 
POC diagnostics that significantly enhances the speed of the process. Microfluidic devices are 
passive requiring no external power input, but instead relying on diffusion and/or capillary action 
to control the assay [212, 213]. Precision is drastically improved in microfluidic devices by using 
software linked to pumps, valves, mixers, etc., to control the movement of fluids. 
Successful immobilization of antibodies on interdigitated array (IDA) microelectrodes fabricated 
on a glass substrate and incorporated within microfluidic immunosensing device has been achieved 
[140]. Similarly, a microfluidic device suitable for the conjugate used in this study need to be 
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designed. Studies on optimizing the detection process in the microfluidic device must be carried 
out. 
 
5.2.2 Design and Optimization of Microfluidic Device 
Microfluidic immunosensing has been demonstrated using CNT matrix [140]. Human serum 
albumin (HSA) protein in a sandwich assay format and polydimethylsiloxane (PDMS) 
microfluidic system were used. The microfluidic system allowed passive sample transport to the 
test zone by capillary action. The test zone had an IDA microelectrode on which primary anti-HSA 
was immobilized. Secondary anti-HSA conjugated with CNTs formed a conducting matrix across 
the IDA which generated electrical signal equivalent to the amount of captured HSA.  
 
The CNT microfluidic immunosensor can be redesigned to use microsized particles of the NMBs 
in place of the nanosized CNTs. The flow system within the microfluidic system will be optimized 
by using a combination of a capillary pump and an absorbent pad. An optimum condition within 
the system can be obtained by manipulating the dimensions of the pump, channel, test zone, and 
IDA. Incorporating the conjugate solution within the system can also eliminate the application of 
multiple reagents which can lead to the overall improvement in the sensitivity of the device. 
Therefore further studies need to be performed in designing and optimizing the detection process 
in a microfluidic device. Simulating the process will also lead to a better understanding of the 




5.2.3 Clinical Trials using Microfluidic Device 
The successful diagnostic of malaria and pregnancy clinical conditions using the 
immunochromatographic assay format has been demonstrated. The purified protein derivative of 
the antigens of the clinical conditions were used. In RDTs, in vivo tests of antigens are rather 
conducted. Hence, for completely successful use of WAG RDTs, tests on the whole genome 
antigens have to be conducted. The whole genome antigen has many other components which do 
interfere with in vivo immunoassay tests. Such components include polysaccharides, lipids, and 
other proteins.  
 
Detection of whole genome antigens in the microfluidic system also need to be carried out. The 
statistical prediction of the confidence interval of the device from a clinical study will be performed 
to determine the sensitivity and specificity of the microfluidic device. The sensitivity gives an 
indication of how the device correctly identifies tested patients with the disease while the 
specificity of the device provides the ability to accurately identify tested patients without the 
disease [214]. Results obtained from testing a sample on the device and testing same sample using 
the ‘gold standard test’ are used as basis. True positive and true negative results obtained are used 
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